{"content":"<li class=\"n-box-item date-title\" data-end=\"1552449599\" data-start=\"1552363200\" data-txt=\"Monday, December 23, 2019\">Tuesday, March 12, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3442110\" data-ts=\"1552428815\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCHC\" target=\"_blank\">HCHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442110-hc2minus-7_1-after-q4-loss-widens\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HC2 -7.1% after Q4 loss widens</a></h4><ul>   <li>HC2 Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HCHC' title='HC2 Holdings, Inc.'>HCHC</a>) is <font color=\"red\">7.1% lower</font> after hours, following a Q4 report which <a href=\"https://seekingalpha.com/news/3442033-hc2-holdings-beats-revenue\" target=\"_blank\">beat revenue expectations</a> after double-digit gains and saw a wider loss and declining EBITDA.</li>    <li>Consolidated revenue grew 14.5%, mainly due to gains in Telecommunications, Insurance and Construction, along with a contribution from a new Broadcasting segment.</li>    <li>Net loss widened to $16.1M from a year-ago loss of $9.2M.</li>    <li>Adjusted EBITDA for the core subsidiaries was $28.5M, down from $32.4M; total adjusted EBITDA (excluding Insurance) was $15.1M, down from $19.7M.</li>    <li>Revenue by segment: Construction, $185.1M (up 5.4%); Marine Services, $44.4M (down 3.7%); Energy, $4.6M (up 12.2%); Telecommunications, $213M (up 17.2%); Insurance, $56M (up 41.8%); Broadcasting, $11.7M (up 144%).</li>    <li>It's guiding to $75M-$80M of adjusted EBITDA for its Construction segment for 2019.</li>    <li>The company's also still looking to explore strategic alternatives for its Global Marine subsidiary, and if sold, proceeds would go to debt reduction.</li>    <li><a href=\"https://seekingalpha.com/pr/17441999-hc2-holdings-reports-fourth-quarter-full-year-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3442110\" data-linked=\"HC2 -7.1% after Q4 loss widens\" data-tweet=\"$HCHC - HC2 -7.1% after Q4 loss widens https://seekingalpha.com/news/3442110-hc2minus-7_1-after-q4-loss-widens?source=tweet\" data-url=\"https://seekingalpha.com/news/3442110-hc2minus-7_1-after-q4-loss-widens\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442105\" data-ts=\"1552427725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442105-wllplus-4_6-ngvtminus-1_3-after-s-and-p-index-changes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WLL +4.6%, NGVT -1.3% after S&amp;P index changes</a></h4><ul>   <li>With TransDigm set to acquire Esterline Technologies (NYSE:<a href='https://seekingalpha.com/symbol/ESL' title='Esterline Technologies Corporation'>ESL</a>), Esterline will <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/890158_ingev4white6.pdf?force_download=true\" target=\"_blank\">drop out of the S&amp;P MidCap 400</a>, to be replaced by SmallCap 600 constituent Ingevity (NYSE:<a href='https://seekingalpha.com/symbol/NGVT' title='Ingevity Corporation'>NGVT</a>).</li>    <li><a href='https://seekingalpha.com/symbol/NGVT' title='Ingevity Corporation'>NGVT</a> is <font color=\"red\">down 1.3%</font> after hours.</li>    <li>Meanwhile Whiting Petroleum (NYSE:<a href='https://seekingalpha.com/symbol/WLL' title='Whiting Petroleum Corporation'>WLL</a>) is <font color=\"green\">up 4.6%</font> as it will move into the SmallCap 600 to replace Ingevity.</li>    <li>The moves are effective prior to the open of trading on Monday, March 18.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3442105\" data-linked=\"WLL +4.6%, NGVT -1.3% after S&amp;P index changes\" data-tweet=\"$ESL $NGVT $WLL - WLL +4.6%, NGVT -1.3% after S&amp;P index changes https://seekingalpha.com/news/3442105-wllplus-4_6-ngvtminus-1_3-after-s-and-p-index-changes?source=tweet\" data-url=\"https://seekingalpha.com/news/3442105-wllplus-4_6-ngvtminus-1_3-after-s-and-p-index-changes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442103\" data-ts=\"1552427418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUNW\" target=\"_blank\">SUNW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442103-sunworksplus-3_8-q4-revenues-top-expectations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunworks +3.8% as Q4 revenues top expectations</a></h4><ul>   <li>Sunworks (NASDAQ:<a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a>) is <font color=\"green\">up 3.8%</font> after hours following a beat in its Q4 revenues and what would have been a narrow profit without a goodwill impairment.</li>    <li>Revenues fell fractionally, and the company lost $1.8M as reported. That included a $1.9M noncash charge, however, and net income would have been $51,000 without it.</li>    <li>Gross margin was 18.6%, the highest in six quarters.</li>    <li>Backlog of projects scheduled for installation in the next 12 months was $46.1M.</li>    <li>For Q1, the company's guiding to seasonally slow revenues exacerbated by unusually rainy California weather: similar to the prior year, about $13M, but increasing throughout 2019.</li>    <li>It expects a Q1 loss but positive net income in subsequent quarters this year.</li>    <li>Previously: <a href=\"https://seekingalpha.com/news/3442005-sunworks-beats-revenue\" target=\"_blank\">Sunworks beats on revenue</a> (Mar. 12 2019)</li><li><a href=\"https://seekingalpha.com/pr/17441952-sunworks-reports-fourth-quarter-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3442103\" data-linked=\"Sunworks +3.8% as Q4 revenues top expectations\" data-tweet=\"$SUNW - Sunworks +3.8% as Q4 revenues top expectations https://seekingalpha.com/news/3442103-sunworksplus-3_8-q4-revenues-top-expectations?source=tweet\" data-url=\"https://seekingalpha.com/news/3442103-sunworksplus-3_8-q4-revenues-top-expectations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442101\" data-ts=\"1552427235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442101-rite-aid-unveils-restructuring-ceo-standley-cfo-kast-others-to-depart\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rite Aid unveils restructuring; CEO Standley, CFO Kast, others to depart</a></h4><ul><li>Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) <font color=\"green\">+4.6%</font> after-hours on news that CEO John Standley and other top executives are leaving the company in a <a href=\"https://seekingalpha.com/pr/17442069-rite-aid-announces-leadership-transition-organizational-restructuring\" target=\"_blank\">restructuring aimed at cutting costs</a>.</li><li>RAD says it will reduce managerial layers and consolidate roles, eliminating ~400 full-time positions, with about two-thirds of the layoffs occurring immediately and the rest taking place by the end of FY 2020.</li><li>As a result of the restructuring, RAD expects to achieve $55M in annual cost savings, with $42M realized within FY 2020, and will incur a one-time $38M restructuring charge to achieve the targeted cost savings.</li><li>In addition to Standley, COO Kermit Crawford and CFO Darren Kast will leave the company, to be replaced by current COO of Rite Aid Stores Bryan Everett and Chief Accounting Officer Matt Schroeder, respectively.</li></ul><div class=\"tiny-share-widget\" data-id=\"3442101\" data-linked=\"Rite Aid unveils restructuring; CEO Standley, CFO Kast, others to depart\" data-tweet=\"$RAD - Rite Aid unveils restructuring; CEO Standley, CFO Kast, others to depart https://seekingalpha.com/news/3442101-rite-aid-unveils-restructuring-ceo-standley-cfo-kast-others-to-depart?source=tweet\" data-url=\"https://seekingalpha.com/news/3442101-rite-aid-unveils-restructuring-ceo-standley-cfo-kast-others-to-depart\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>275&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442095\" data-ts=\"1552426398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442095-cohu-ntra-cara-and-clw-among-after-hours-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">COHU, NTRA, CARA and CLW among after hours movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/CLNE' title='Clean Energy Fuels Corp.'>CLNE</a> <font color=\"green\">+11.1%</font>. <a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics, Inc.'>CARA</a> <font color=\"green\">+10.4%</font>. <a href='https://seekingalpha.com/symbol/NTRA' title='Natera, Inc.'>NTRA</a> <font color=\"green\">+8.3%</font>. <a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a> <font color=\"green\">+7.8%</font>. <a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a> <font color=\"green\">+7.5%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/SIEN' title='Sientra, Inc.'>SIEN</a> <font color=\"red\">-16.5%</font>. <a href='https://seekingalpha.com/symbol/NM' title='Navios Maritime Holdings Inc.'>NM</a> <font color=\"red\">-9.0%</font>. <a href='https://seekingalpha.com/symbol/COHU' title='Cohu, Inc.'>COHU</a> <font color=\"red\">-7.7%</font>. <a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a> <font color=\"red\">-7.5%</font>. <a href='https://seekingalpha.com/symbol/CLW' title='Clearwater Paper Corporation'>CLW</a> <font color=\"red\">-6.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3442095\" data-linked=\"COHU, NTRA, CARA and CLW among after hours movers\" data-tweet=\"$CLNE $CARA $NTRA - COHU, NTRA, CARA and CLW among after hours movers https://seekingalpha.com/news/3442095-cohu-ntra-cara-and-clw-among-after-hours-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3442095-cohu-ntra-cara-and-clw-among-after-hours-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442093\" data-ts=\"1552426099\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HK\" target=\"_blank\">HK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442093-halcon-resourcesplus-5-after-q4-results-to-review-financial-strategic-options\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halcón Resources +5% after Q4 results; to review financial, strategic options</a></h4><ul><li>Halcón Resources (NYSE:<a href='https://seekingalpha.com/symbol/HK' title='Halcón Resources Corporation'>HK</a>) <font color=\"green\">+4.8%</font> after-hours as it posts a larger than expected <a href=\"https://seekingalpha.com/news/3442037-halcon-resources-misses-0_02-misses-revenue\" target=\"_blank\">Q4 loss</a> but says it plans to engage advisors for a review of its financial and strategic options.</li><li>HK says the review will include \"an assessment of value under various go-forward scenarios including a potential sale of select assets, M&amp;A options and... a review of alternative financing options to ensure Halcón has sufficient liquidity and financial flexibility going forward.\"</li><li>HK says Q4 net production averaged  nearly 17.2K boe/day, comprised of 69% oil, 14% natural gas liquids and 17% natural gas; third party sour gas takeaway constraints in the  Monument Draw area resulted in significantly lower gas and NGL volumes  than expected but HK expects to resolve the takeaway issue when its sour gas  treatment plant is completed later this month.</li><li>For FY 2019, HK forecasts production of 19K-22K boe/day and total capex of $250M-$290M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3442093\" data-linked=\"Halcón Resources +5% after Q4 results; to review financial, strategic options\" data-tweet=\"$HK $HKRS - Halcón Resources +5% after Q4 results; to review financial, strategic options https://seekingalpha.com/news/3442093-halcon-resourcesplus-5-after-q4-results-to-review-financial-strategic-options?source=tweet\" data-url=\"https://seekingalpha.com/news/3442093-halcon-resourcesplus-5-after-q4-results-to-review-financial-strategic-options\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442091\" data-ts=\"1552425837\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNCR\" target=\"_blank\">SNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442091-synchronossminus-7_5-revenues-dip-and-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synchronoss -7.5% as revenues dip and miss</a></h4><ul>   <li>Synchronoss (NASDAQ:<a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a>) is <font color=\"red\">7.5% lower</font> postmarket after its <a href=\"https://seekingalpha.com/news/3442002-synchronoss-technologies-eps-2_49\" target=\"_blank\">Q4 revenues</a> dropped by double digits and missed consensus expectations.</li>    <li>The company recorded a GAAP net loss of $101.9M, though that was affected by $109.1M in pretax noncash asset impairments.</li>    <li>Adjusted EBITDA came to $15.4M, up 64.9% from Q3, but down from a year-ago $31M. EBITDA margin rose to 18.8% from Q3's 11.2%.</li>    <li>Of revenues of $82.1M (down 23% Y/Y), 83% was recurring revenue.</li>    <li>Cash flow from operations came to $29.3M for the quarter.</li>    <li><a href=\"https://seekingalpha.com/pr/17441911-synchronoss-technologies-announces-fourth-quarter-full-year-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3442091\" data-linked=\"Synchronoss -7.5% as revenues dip and miss\" data-tweet=\"$SNCR - Synchronoss -7.5% as revenues dip and miss https://seekingalpha.com/news/3442091-synchronossminus-7_5-revenues-dip-and-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3442091-synchronossminus-7_5-revenues-dip-and-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442075\" data-ts=\"1552423441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHFS\" target=\"_blank\">CHFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442075-chf-closes-12_4-capital-raise-shares-up-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CHF closes $12.4 capital raise; shares up 5% after hours</a></h4><ul><li>Thinly traded nano cap CHF Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a>) has <a href=\"https://seekingalpha.com/pr/17441949-chf-solutions-inc-announces-closing-12_42-million-underwritten-public-offering-full-exercise\" target=\"_blank\">closed</a> its <a href=\"https://seekingalpha.com/news/3436636-chf-solutions-files-upsized-equity-offering-shares-2-percent\" target=\"_blank\">equity offering</a>, yielding gross proceeds of ~$12.4M.</li><li>Shares are up <font color=\"green\">5%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3442075\" data-linked=\"CHF closes $12.4 capital raise; shares up 5% after hours\" data-tweet=\"$CHFS - CHF closes $12.4 capital raise; shares up 5% after hours https://seekingalpha.com/news/3442075-chf-closes-12_4-capital-raise-shares-up-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3442075-chf-closes-12_4-capital-raise-shares-up-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442073\" data-ts=\"1552423219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442073-inovio-q4-top-line-down-72-shares-down-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio Q4 top line down 72%; shares down 2% after hours</a></h4><ul><li>Inovio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a>) <a href=\"https://seekingalpha.com/pr/17441972-inovio-pharmaceuticals-reports-2018-fourth-quarter-year-end-financial-results\" target=\"_blank\">Q4 results</a>:</li><li>Revenue down 72% to $2.5M, operating expenses relatively flat at $32.0M.</li><li><strong>Key 2019 milestones</strong>:</li><li>Interim data from Phase 1/2 study of INO-5401 + INO-9012, combined with Regeneron Pharmaceuticals' cemiplimab (REGN2810), in newly diagnosed glioblastoma.</li><li>Interim data from Phase 1/2a study of INO-5401 + INO-9012, combined with Roche's Tecentriq (atezolizumab), in bladder cancer.</li><li>Interim data from Phase 1/2a study of MERS vaccine. A Phase 2 trial in the Middle East should launch in H2.</li><li>Interim data from Zika vaccine study.</li><li>First in-human trial of Lassa fever vaccine should launch in Q2.</li><li>Shares are down <font color=\"red\">2%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3442073\" data-linked=\"Inovio Q4 top line down 72%; shares down 2% after hours\" data-tweet=\"$INO - Inovio Q4 top line down 72%; shares down 2% after hours https://seekingalpha.com/news/3442073-inovio-q4-top-line-down-72-shares-down-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3442073-inovio-q4-top-line-down-72-shares-down-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442053\" data-ts=\"1552422419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYPT\" target=\"_blank\">EYPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442053-eyepoint-launches-eye-drop-dexycu-in-u-s-shares-up-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyePoint launches eye drop Dexycu in U.S.; shares up 6% after hours</a></h4><ul><li>EyePoint Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a>) <a href=\"https://seekingalpha.com/pr/17441996-eyepoint-pharmaceuticals-announces-u-s-commercial-launch-dexycutm-dexamethasone-intraocular\" target=\"_blank\">announces </a>the U.S. commercial launch of DEXYCU (dexamethasone intraocular suspension) 9% for the single-dose treatment of postoperative inflammation following cataract surgery.</li><li>The FDA approved the eye drop last month.</li><li>Shares are up <font color=\"green\">6%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3442053\" data-linked=\"EyePoint launches eye drop Dexycu in U.S.; shares up 6% after hours\" data-tweet=\"$EYPT - EyePoint launches eye drop Dexycu in U.S.; shares up 6% after hours https://seekingalpha.com/news/3442053-eyepoint-launches-eye-drop-dexycu-in-u-s-shares-up-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3442053-eyepoint-launches-eye-drop-dexycu-in-u-s-shares-up-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442047\" data-ts=\"1552422308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HROW\" target=\"_blank\">HROW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442047-harrow-health-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harrow Health beats on revenue</a></h4><ul><li>Harrow Health (NASDAQ:<a href='https://seekingalpha.com/symbol/HROW' title='Harrow Health, Inc.'>HROW</a>): Q4 net income of $18.1M</li><li>Revenue of $11.4M (+55.3% Y/Y) <font color=\"green\">beats by $0.44M</font>.</li><li>Shares <font color=\"green\">+2.8%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17441903-harrow-health-announces-fourth-quarter-2018-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3442047\" data-linked=\"Harrow Health beats on revenue\" data-tweet=\"$HROW - Harrow Health beats on revenue https://seekingalpha.com/news/3442047-harrow-health-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3442047-harrow-health-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442039\" data-ts=\"1552421984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSTM\" target=\"_blank\">VSTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442039-verastem-down-11-on-q4-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verastem down 11% on Q4 report</a></h4><ul><li>Verastem Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>) Q4 <a href=\"https://seekingalpha.com/pr/17441966-verastem-oncology-announces-fourth-quarter-full-year-2018-financial-results-corporate\" target=\"_blank\">highlights</a>:</li><li>Copiktra sales: $1.2M, below consensus of $2.9M. Net loss was ($11.3M) or ($0.15) per share. Quick asset balance at year-end: $249.7M.</li><li>The FDA approved Copiktra in late September 2018 under accelerated status.</li><li>Confirmatory trials to support full approval will start this year.</li><li>Shares are down <font color=\"red\">11%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3442039\" data-linked=\"Verastem down 11% on Q4 report\" data-tweet=\"$VSTM - Verastem down 11% on Q4 report https://seekingalpha.com/news/3442039-verastem-down-11-on-q4-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3442039-verastem-down-11-on-q4-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442029\" data-ts=\"1552421799\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442029-pareteumplus-4_9-revenue-jumps-multiples-guidance-stays-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum +4.9% as revenue jumps by multiples, guidance stays high</a></h4><ul>   <li>Pareteum (NASDAQ:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) is <font color=\"green\">up 4.9%</font> postmarket after it topped expectations with its Q4 earnings, after revenues grew 256% with accretive help from its Artilium acquisition.</li>    <li>EBITDA rose 82% to $2.34M.</li>    <li>In December, it says Global Software Defined Cloud revenue made up 51% of the total, with 35% in Managed Services and 14% in Super API.</li>    <li>In operating metrics, 36-month backlog quadrupled to $615M for 2018, up from 2017's $147M. Conversion rate to revenue was 100%.</li>    <li>And connections increased 252% to 4.609M for the year, and rose 59% sequentially in Q4.</li>    <li>For the full year, it sees revenues of $105M-$115M (vs. one estimate for $108.7M), as well as positive adjusted EBITDA and cash flow (net of restructuring/acquisition costs). That's 225-260% revenue growth Y/Y, and the company expects to update guidance quarterly.</li>    <li><a href=\"http://public.viavid.com/index.php?id=133208\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17441912-pareteum-announces-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3442029\" data-linked=\"Pareteum +4.9% as revenue jumps by multiples, guidance stays high\" data-tweet=\"$TEUM - Pareteum +4.9% as revenue jumps by multiples, guidance stays high https://seekingalpha.com/news/3442029-pareteumplus-4_9-revenue-jumps-multiples-guidance-stays-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3442029-pareteumplus-4_9-revenue-jumps-multiples-guidance-stays-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442020\" data-ts=\"1552421629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZAGG\" target=\"_blank\">ZAGG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442020-zagg-battles-through-q4-sales-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zagg battles through Q4 sales drop</a></h4><ul>  <li>Zagg (NASDAQ:<a href='https://seekingalpha.com/symbol/ZAGG' title='ZAGG Inc'>ZAGG</a>) is <font color=\"green\">up 0.2%</font> in AH trading after posting <a href=\"https://seekingalpha.com/pr/17441963-zagg-reports-fourth-quarter-full-year-2018-results\" target=\"_blank\">Q4 results</a> ahead of expectations.</li>  <li>Adjusted EBITDA fell to $28.1M from $35.8M a year ago. Gross profit improved to 35% of sales vs. 32% a year ago.</li>   <li>\"While soft demand for smartphone devices has created some headwinds for our business, we were able to increase screen protection sales double digits through new product innovation, strong international growth and some domestic retailer requests for early deliveries ahead of a potential tariff increase,\" notes Zagg CEO Chris Ahern.</li>  <li>Looking ahead, Zagg sees full-year sales of $610M vs. $630M and adjusted EBITDA of $82M to $86M. EPS of $1.47 to $1.60 is anticipated vs. $1.58 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3442013-zagg-beats-0_05-beats-revenue\" target=\"_blank\">Zagg beats by $0.05, beats on revenue</a> (March 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3442020\" data-linked=\"Zagg battles through Q4 sales drop\" data-tweet=\"$ZAGG - Zagg battles through Q4 sales drop https://seekingalpha.com/news/3442020-zagg-battles-through-q4-sales-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3442020-zagg-battles-through-q4-sales-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442007\" data-ts=\"1552421253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442007-neovasc-readies-stock-offering-shares-down-13-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc readies stock offering; shares down 13% after hours</a></h4><ul><li>Nano cap Neovasc (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>) is down <font color=\"red\">13%</font> after hours in response to its <a href=\"https://seekingalpha.com/pr/17441894-neovasc-announces-proposed-public-offering-common-shares\" target=\"_blank\">public stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3442007\" data-linked=\"Neovasc readies stock offering; shares down 13% after hours\" data-tweet=\"$NVCN - Neovasc readies stock offering; shares down 13% after hours https://seekingalpha.com/news/3442007-neovasc-readies-stock-offering-shares-down-13-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3442007-neovasc-readies-stock-offering-shares-down-13-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3442006\" data-ts=\"1552421251\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLNE\" target=\"_blank\">CLNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3442006-clean-energy-fuels-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clean Energy Fuels beats by $0.03, beats on revenue</a></h4><ul><li>Clean Energy Fuels (NASDAQ:<a href='https://seekingalpha.com/symbol/CLNE' title='Clean Energy Fuels Corp.'>CLNE</a>): Q4 Non-GAAP EPS of -$0.01 <span style=\"color:green\">beats by $0.03</span>; GAAP EPS of $0.03.</li><li>Revenue of $96.23M (+7.8% Y/Y) <font color=\"green\">beats by $18.7M</font>.</li><li>Shares <font color=\"green\">+4.85%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17441928-clean-energy-reports-98_7-million-gallons-delivered-revenue-96_2-million-fourth-quarter-2018\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3442006\" data-linked=\"Clean Energy Fuels beats by $0.03, beats on revenue\" data-tweet=\"$CLNE - Clean Energy Fuels beats by $0.03, beats on revenue https://seekingalpha.com/news/3442006-clean-energy-fuels-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3442006-clean-energy-fuels-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441987\" data-ts=\"1552420120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441987-news-corp-pushing-for-google-breakup-eyeing-mergermarket-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">News Corp.: Pushing for Google breakup, eyeing Mergermarket buy</a></h4><ul>   <li>In News Corp. news (<a href='https://seekingalpha.com/symbol/NWS' title='News Corporation'>NWS</a> <font color=\"red\">-0.6%</font>, <a href='https://seekingalpha.com/symbol/NWSA' title='News Corporation'>NWSA</a> <font color=\"red\">-0.6%</font>), Rupert Murdoch's News Corp. Australia is asking that country's regulators to break up Google's (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet Inc.'>GOOG</a> <font color=\"green\">+1.8%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet Inc.'>GOOGL</a> <font color=\"green\">+1.9%</font>) advertising business for being damaging to the media industry.</li>    <li>A filing from Murdoch's Aussie unit says more regulatory oversight is needed: \"The market power that Google and Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"red\">-0.1%</font>) occupy makes it difficult even for sophisticated and experienced businesses like News Corp. Australia to negotiate any terms of business.\"</li>    <li>For specific remedies, News Corp. is suggesting that Google divest Google Search or Google Ad Manager.</li>    <li>Meanwhile, the <i>Financial Times</i> reported that News Corp. and private-equity firms are <a href=\"https://www.ft.com/content/5a79d412-444d-11e9-a965-23d669740bfb\" target=\"_blank\">set to bid for Acuris</a>, the parent of Mergermarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441987\" data-linked=\"News Corp.: Pushing for Google breakup, eyeing Mergermarket buy\" data-tweet=\"$NWS $NWSA $GOOG - News Corp.: Pushing for Google breakup, eyeing Mergermarket buy https://seekingalpha.com/news/3441987-news-corp-pushing-for-google-breakup-eyeing-mergermarket-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3441987-news-corp-pushing-for-google-breakup-eyeing-mergermarket-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441985\" data-ts=\"1552419161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WCG\" target=\"_blank\">WCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441985-two-big-blues-merge-to-create-16b-health-insurer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Two big blues merge to create $16B health insurer</a></h4><ul><li>Portland, OR-based Cambia Health Solutions and Durham-based Blue Shield of North Carolina have <a href=\"https://www.wsj.com/articles/major-blue-health-insurers-to-combine-11552411620\" target=\"_blank\">agreed to combine</a> to create a health insurer that covers more than 6M people and generates ~$16B in revenue. The combined organization will do business under the Cambia name and will be led by current BCNC chief Patrick Conway. Current Cambia CEO Mark Ganz will be Executive Chairman.</li><li>Legally, BCNC will remain a separate company, retaining its name and assets, but it will sign a 20-year contract with the revamped Cambia to manage its operations. Neither company will formerly acquire the other or have to pay out any cash.</li><li>Related tickers: WellCare Health Plans (<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a> <font color=\"red\">-0.8%</font>), UnitedHealth Group (<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a> <font color=\"green\">+1.4%</font>), Molina Healthcare (<a href='https://seekingalpha.com/symbol/MOH' title='Molina Healthcare, Inc.'>MOH</a> <font color=\"green\">+2.1%</font>), Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color=\"green\">+0.2%</font>), Cigna (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color=\"green\">+0.7%</font>), Centene (<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a> <font color=\"green\">+1.6%</font>), Anthem (<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color=\"green\">+0.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441985\" data-linked=\"Two big blues merge to create $16B health insurer\" data-tweet=\"$WCG $UNH $MOH - Two big blues merge to create $16B health insurer https://seekingalpha.com/news/3441985-two-big-blues-merge-to-create-16b-health-insurer?source=tweet\" data-url=\"https://seekingalpha.com/news/3441985-two-big-blues-merge-to-create-16b-health-insurer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441980\" data-ts=\"1552418356\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIX\" target=\"_blank\">EIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441980-socal-edison-moves-to-sell-10-and-30-year-bonds-elevated-yields\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SoCal Edison moves to sell 10- and 30-year bonds at elevated yields</a></h4><ul><li>Southern California Edison (<a href='https://seekingalpha.com/symbol/EIX' title='Edison International'>EIX</a> <font color='green'>+1.6%</font>) is finding it <a href=\"https://www.wsj.com/articles/sce-paying-up-in-bond-sale-showing-impact-of-state-fires-11552411751\" target=\"_blank\">costlier to borrow money</a> than it did in 2018, as the utility moves to sell 10- and 30-year secured bonds at significantly higher yield premiums to U.S. Treasurys than in three bond sales last year, <em>WSJ</em> reports.</li><li>The planned sale comes after PG&amp;E, California\u2019s largest utility, filed for bankruptcy protection in January in the wake of potentially tens of billions of dollars in potential liabilities from its role in igniting wildfires.</li><li>SoCal Edison is poised to sell $500M of 10-year bonds at a 1.65 yield-premium vs. Treasurys and $600M of 30-year bonds at a 1.9 percentage point spread, which should translate to a ~4.3% yield for the 10-year bond and ~5% for the 30-year bond, according to the report.</li><li>Last year, SoCal Edison sold 10-year secured bonds at a 3.672% yield, or 0.8 percentage-point spread, and 30-year bonds at a 4.136% yield, or one percentage-point spread.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441980\" data-linked=\"SoCal Edison moves to sell 10- and 30-year bonds at elevated yields\" data-tweet=\"$EIX - SoCal Edison moves to sell 10- and 30-year bonds at elevated yields https://seekingalpha.com/news/3441980-socal-edison-moves-to-sell-10-and-30-year-bonds-elevated-yields?source=tweet\" data-url=\"https://seekingalpha.com/news/3441980-socal-edison-moves-to-sell-10-and-30-year-bonds-elevated-yields\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441972\" data-ts=\"1552417167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441972-microcaps-dominate-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate tech movers</a></h4><ul><li><strong>Gainers: </strong>VivoPower International (NASDAQ:<a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a>) <font color=\"green\">+148%</font>. Sphere 3D (NASDAQ:<a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a>) <font color=\"green\">+19%</font>. Qumu Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/QUMU' title='Qumu Corporation'>QUMU</a>) <font color=\"green\">+15%</font>. Switch (NYSE:<a href='https://seekingalpha.com/symbol/SWCH' title='Switch, Inc.'>SWCH</a>) <font color=\"green\">+14%</font>. Internap Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/INAP' title='Internap Corporation'>INAP</a>) <font color=\"green\">+13%</font>.</li> <li><strong>Losers: </strong>B.O.S Better Online Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S Better Online Solutions Ltd.'>BOSC</a>) <font color=\"red\">-23%</font>. VirnetX Holding (NYSEMKT:<a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corp'>VHC</a>) <font color=\"red\">-16%</font>. Summit Wireless Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/WISA' title='Summit Wireless Technologies, Inc.'>WISA</a>) <font color=\"red\">-11%</font>. Sigma Labs (NASDAQ:<a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a>) <font color=\"red\">-10%</font>. FTE Networks (NYSEMKT:<a href='https://seekingalpha.com/symbol/FTNW' title='FTE Networks, Inc.'>FTNW</a>) <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441972\" data-linked=\"Microcaps dominate tech movers\" data-tweet=\"$VVPR $ANY $QUMU - Microcaps dominate tech movers https://seekingalpha.com/news/3441972-microcaps-dominate-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441972-microcaps-dominate-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441966\" data-ts=\"1552416296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/I\" target=\"_blank\">I</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441966-intelsatplus-3_7-new-street-sees-positive-in-airwaves-act-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat +3.7% as New Street sees positive in Airwaves Act delay</a></h4><ul>    <li>Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat S.A.'>I</a>) is jumping, <font color=\"green\">up 3.7%</font> now, after New Street Research says the Airwaves Act appears to be on hold.</li>    <li>That's a positive development for the satellite firm, New Street says.</li>    <li>Shares topped out at $18.88 on NYSE today, helping make up some of what has been a steep decline over the past week (<font color=\"red\">down 16.2%</font> over the past five days).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441966\" data-linked=\"Intelsat +3.7% as New Street sees positive in Airwaves Act delay\" data-tweet=\"$I - Intelsat +3.7% as New Street sees positive in Airwaves Act delay https://seekingalpha.com/news/3441966-intelsatplus-3_7-new-street-sees-positive-in-airwaves-act-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3441966-intelsatplus-3_7-new-street-sees-positive-in-airwaves-act-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441964\" data-ts=\"1552415802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441964-boeing-to-make-significant-cockpit-software-update-to-737-max-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing to make significant cockpit software update to 737 MAX - WSJ</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color=\"red\">-5.2%</font>) is <a href=\"https://www.wsj.com/articles/boeing-to-make-key-change-in-max-cockpit-software-11552413489\" target=\"_blank\">making a key software change</a> to a flight control system in the new 737 MAX aircraft implicated in last year\u2019s Lion Air crash, coming amid growing worldwide unease about the plane's safety following a second crash of the model, <em>WSJ</em> reports.</li><li>The change, which was in the works before last weekend's Ethiopian Airlines crash, will include a change to use  multiple data feeds in the MAX\u2019s stall-prevention system instead of the current reliance on a single sensor.</li><li>U.S. aviation regulators are expected to mandate the change by the end of April, according to the report.</li><li>Separately, the European Union Aviation Safety Agency says it is suspending all flights of Boeing\u2019s 737 MAX 8 and 9 jets pending more information.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441964\" data-linked=\"Boeing to make significant cockpit software update to 737 MAX - WSJ\" data-tweet=\"$BA - Boeing to make significant cockpit software update to 737 MAX - WSJ https://seekingalpha.com/news/3441964-boeing-to-make-significant-cockpit-software-update-to-737-max-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3441964-boeing-to-make-significant-cockpit-software-update-to-737-max-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>146&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441963\" data-ts=\"1552415765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441963-american-airlines-flight-attendants-press-for-737-max-grounding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Airlines flight attendants press for 737 Max grounding</a></h4><ul> <li>Flight attendants with American Airlines Group (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group Inc.'>AAL</a>) have asked the company to ground Boeing 737 Max planes until more can be determined about the crash last weekend.</li> <li>\"Our Flight Attendants are very concerned with the recent Ethiopian Airlines flight 302 crash, which has raised safety concerns with the 737 MAX 8,\" says Association of Professional Flight Attendant President Lori Bassani.</li><li>The union says it's in contact with AAL management.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3441963\" data-linked=\"American Airlines flight attendants press for 737 Max grounding\" data-tweet=\"$AAL - American Airlines flight attendants press for 737 Max grounding https://seekingalpha.com/news/3441963-american-airlines-flight-attendants-press-for-737-max-grounding?source=tweet\" data-url=\"https://seekingalpha.com/news/3441963-american-airlines-flight-attendants-press-for-737-max-grounding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441959\" data-ts=\"1552415399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHK\" target=\"_blank\">CHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441959-chesapeake-energyplus-5-cfo-dellosso-buys-590k-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chesapeake Energy +5% as CFO Dell&#39;Osso buys 590K shares</a></h4><ul><li>Chesapeake Energy (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='green'>+5.5%</font>) jumps after a new SEC filing showed CFO Domenic Dell'Osso <a href=\"https://www.streetinsider.com/SEC+Filings/Form+4+CHESAPEAKE+ENERGY+CORP+For%3A+Mar+07+Filed+by%3A+DELL%26apos%3BOSSO+DOMENIC+J+JR/15244334.html\" target=\"_blank\">acquired nearly 590K additional shares</a> on March 7, raising his direct stake to nearly 2.06M CHK shares.</li><li>Several other CHK insiders also made purchases, including VPs Jason Pigott, James Webb and William Buergler.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441959\" data-linked=\"Chesapeake Energy +5% as CFO Dell&#39;Osso buys 590K shares\" data-tweet=\"$CHK - Chesapeake Energy +5% as CFO Dell&#39;Osso buys 590K shares https://seekingalpha.com/news/3441959-chesapeake-energyplus-5-cfo-dellosso-buys-590k-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3441959-chesapeake-energyplus-5-cfo-dellosso-buys-590k-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441953\" data-ts=\"1552413727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441953-key-energy-services-and-chaparral-energy-among-energy-materials-gainers-valhi-and-lilis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Key Energy Services and Chaparral Energy among Energy/Materials gainers; Valhi and Lilis Energy among losers</a></h4><ul><li><b>Gainers: </b>Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+24%</font>. Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy, Inc.'>CHAP</a>) <font color=\"green\">+22%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware Inc.'>PHUN</a>) <font color=\"green\">+16%</font>. SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"green\">+12%</font>. ION Geophysical (NYSE:<a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Valhi (NYSE:<a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a>) <font color=\"red\">-28%</font>. Lilis Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a>) <font color=\"red\">-9%</font>. Sundance Energy Australia (NASDAQ:<a href='https://seekingalpha.com/symbol/SNDE' title='Sundance Energy Australia Limited'>SNDE</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441953\" data-linked=\"Key Energy Services and Chaparral Energy among Energy/Materials gainers; Valhi and Lilis Energy among losers\" data-tweet=\"$KEG $CHAP $SAEX - Key Energy Services and Chaparral Energy among Energy/Materials gainers; Valhi and Lilis Energy among losers https://seekingalpha.com/news/3441953-key-energy-services-and-chaparral-energy-among-energy-materials-gainers-valhi-and-lilis?source=tweet\" data-url=\"https://seekingalpha.com/news/3441953-key-energy-services-and-chaparral-energy-among-energy-materials-gainers-valhi-and-lilis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441952\" data-ts=\"1552413687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADT\" target=\"_blank\">ADT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441952-adtminus-13-after-earnings-underwhelm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ADT -13% after earnings underwhelm</a></h4><ul> <li>ADT (NYSE:<a href='https://seekingalpha.com/symbol/ADT' title='ADT Inc.'>ADT</a>) is <font color=\"red\">down 13.3%</font> after the company's guidance disappointed yesterday and Citi followed up with a downgrade to Neutral from Buy.</li> <li>During the earnings call (<a href=\"https://seekingalpha.com/article/4247932-adt-inc-adt-ceo-jim-devries-q4-2018-results-earnings-call-transcript\" target=\"_blank\">transcript</a>), ADT execs updated on the company's relationship with Amazon. \"We\u2019re working with Amazon to refine the go-to-market strategy. They have been strong partners to us, but the full launch will be made when Amazon and ADT are ready, and we don\u2019t yet have a date for that,\" noted CEO Jim DeVries.</li> <li>Shares of ADT trade at their lowest level since early January.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441643-adt-lower-light-ebitda-guidance\" target=\"_blank\">ADT lower on light EBITDA guidance</a> (March 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441952\" data-linked=\"ADT -13% after earnings underwhelm\" data-tweet=\"$ADT - ADT -13% after earnings underwhelm https://seekingalpha.com/news/3441952-adtminus-13-after-earnings-underwhelm?source=tweet\" data-url=\"https://seekingalpha.com/news/3441952-adtminus-13-after-earnings-underwhelm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441949\" data-ts=\"1552413461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PNGAY\" target=\"_blank\">PNGAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441949-ping-insuranceplus-5_0-after-div-boost-stock-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ping An Insurance +5.0% after div boost, stock buyback</a></h4><ul><li>Ping An Insurance Company of China (<a href='https://seekingalpha.com/symbol/PNGAY' title='Ping An Insurance &#40;Group&#41; Company of China, Ltd.'>OTCPK:PNGAY</a>) (<a href='https://seekingalpha.com/symbol/PIAIF' title='Ping An Insurance &#40;Group&#41; Company of China, Ltd.'>OTCPK:PIAIF</a>) <font color=\"green\">surges 5.0% </font>after<a href=\"https://seekingalpha.com/pr/17441642-ping-reports-steady-growth-18_9-percent-operating-profit-attributable-shareholders-parent\" target=\"_blank\"> boosting its dividend</a> and announcing its first stock buyback plan.</li><li>The group proposed a final cash dividend of RMB 1.10 per share ($0.16), bringing the total ordinary dividend per share to RMB 1.72, up 15% from a year ago.</li><li>In addition, Ping An adopts a share repurchase plan of RMB 5B-RMB 10B ($750M-$1.49B) that it will pay for using internal resources.</li><li>FY2018 operating profit attributable to shareholders of the parent company rose 19% to RMB 112.6B from RMB 94.7B in FY2017.</li><li>FY2018 operating return on equity was 21.9% vs. 22.0% a year earliers.</li><li>FY2018 net profit attributable to shareholders of the parent company increased 21% to RMB 107.4B from RMG 89.1B.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441922-ping-insurance-company-china-declares-final-dividend-rmb-1_10-share\" target=\"_blank\">Ping An Insurance Company of China declares final dividend of RMB 1.10/share</a> (March 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441949\" data-linked=\"Ping An Insurance +5.0% after div boost, stock buyback\" data-tweet=\"$PNGAY $PNGAY $PIAIF - Ping An Insurance +5.0% after div boost, stock buyback https://seekingalpha.com/news/3441949-ping-insuranceplus-5_0-after-div-boost-stock-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3441949-ping-insuranceplus-5_0-after-div-boost-stock-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441938\" data-ts=\"1552411209\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441938-blackberry-sets-up-unit-to-serve-u-s-government\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry sets up unit to serve U.S. government</a></h4><ul>   <li>In a move to deepen ties to U.S. federal agencies, BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Limited'>BB</a>) has established a new <a href=\"https://seekingalpha.com/pr/17441737-blackberry-establishes-new-subsidiary-better-serve-u-s-government\" target=\"_blank\">Government Solutions unit</a>.</li>    <li>Shares have jumped to a session high, <font color=\"green\">up 2.3%</font>.</li>    <li>The new division will operate as a wholly owned subsidiary and pursue acceleration of the company's Federal Risk and Authorization Management Program initiatives.</li>    <li>It will be headquartered in Washington, D.C., and be led by retired Coast Guard Rear Admiral Robert \"Bob\" Day Jr., who had joined BlackBerry in 2016.</li>    <li>BlackBerry Government Solutions will have a separate governance structure from the corporate parent in order to comply with U.S. national security requirements.</li>    <li>Elsewhere, BlackBerry notes NATO has <a href=\"https://seekingalpha.com/pr/17441735-nato-selects-blackberrys-encrypted-voice-technology-secure-calls\" target=\"_blank\">chosen its voice technology</a> to encrypt conversations. NATO's Communications and Information Agency has awarded a contract to BlackBerry's SecuSUITE for Government.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441938\" data-linked=\"BlackBerry sets up unit to serve U.S. government\" data-tweet=\"$BB - BlackBerry sets up unit to serve U.S. government https://seekingalpha.com/news/3441938-blackberry-sets-up-unit-to-serve-u-s-government?source=tweet\" data-url=\"https://seekingalpha.com/news/3441938-blackberry-sets-up-unit-to-serve-u-s-government\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>105&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441936\" data-ts=\"1552410179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MO\" target=\"_blank\">MO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441936-altria-slips-after-new-fda-chief-named\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altria slips after new FDA chief named</a></h4><ul><li>Altria Group (<a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color=\"red\">-0.7%</font>) is under modest pressure in apparent response to the <a href=\"https://seekingalpha.com/news/3441914-nci-director-sharpless-head-fda\" target=\"_blank\">naming</a> of NCI Director Norman Sharpless to head the FDA. Considering his background, investors expect him to have a critical eye on tobacco and e-cigarette use, especially among young people.</li><li>Related tickers: British American Tobacco (<a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c.'>BTI</a> <font color=\"green\">+0.2%</font>), Vape Holdings (<a href='https://seekingalpha.com/symbol/VAPE' title='Vape Holdings, Inc.'>OTCPK:VAPE</a> <font color=\"red\">-5.9%</font>), Hop-On (<a href='https://seekingalpha.com/symbol/HPNN' title='Hop-On Inc.'>OTCPK:HPNN</a>), mCIG (<a href='https://seekingalpha.com/symbol/MCIG' title='mCig, Inc.'>OTCPK:MCIG</a> <font color=\"red\">-1.6%</font>), Neutra (<a href='https://seekingalpha.com/symbol/NTRR' title='Neutra Corp.'>OTCQB:NTRR</a>), VaporBrands International (<a href='https://seekingalpha.com/symbol/VAPR' title='VaporBrands International, Inc.'>OTCPK:VAPR</a>), American Heritage International (<a href='https://seekingalpha.com/symbol/AHII' title='American Heritage International Inc.'>OTC:AHII</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441936\" data-linked=\"Altria slips after new FDA chief named\" data-tweet=\"$MO $BTI $VAPE - Altria slips after new FDA chief named https://seekingalpha.com/news/3441936-altria-slips-after-new-fda-chief-named?source=tweet\" data-url=\"https://seekingalpha.com/news/3441936-altria-slips-after-new-fda-chief-named\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441933\" data-ts=\"1552410037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441933-fanhua-only-financial-gainer-hercules-capital-and-x-financial-in-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fanhua only financial gainer; Hercules Capital and X Financial in losers</a></h4><ul><li><b>Gainers: </b>Fanhua (NASDAQ:<a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Hercules Capital (NYSE:<a href='https://seekingalpha.com/symbol/HTGC' title='Hercules Capital, Inc.'>HTGC</a>) <font color=\"red\">-8%</font>. X Financial (NYSE:<a href='https://seekingalpha.com/symbol/XYF' title='X Financial'>XYF</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441933\" data-linked=\"Fanhua only financial gainer; Hercules Capital and X Financial in losers\" data-tweet=\"$FANH $HTGC $XYF - Fanhua only financial gainer; Hercules Capital and X Financial in losers https://seekingalpha.com/news/3441933-fanhua-only-financial-gainer-hercules-capital-and-x-financial-in-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441933-fanhua-only-financial-gainer-hercules-capital-and-x-financial-in-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441930\" data-ts=\"1552409797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KAYS\" target=\"_blank\">KAYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441930-kaya-holdings-up-13-on-franchise-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kaya Holdings up 13% on franchise plan</a></h4><ul><li>Thinly traded nano cap Kaya Holdings (<a href='https://seekingalpha.com/symbol/KAYS' title='Kaya Holdings, Inc.'>OTCQB:KAYS</a> <font color=\"green\">+12.9%</font>) is up on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/17441618-cannabis-company-kaya-holdings-inc-otcqb-kays-announces-plan-sell-kaya-shack-retail-marijuana\" target=\"_blank\">plan to franchise</a> the Kaya Shack brand of cannabis dispensaries in Canada. It is in the final stages of talks with a franchise consultant to lead the effort aimed at rolling out 75 locations there.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441930\" data-linked=\"Kaya Holdings up 13% on franchise plan\" data-tweet=\"$KAYS - Kaya Holdings up 13% on franchise plan https://seekingalpha.com/news/3441930-kaya-holdings-up-13-on-franchise-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3441930-kaya-holdings-up-13-on-franchise-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441921\" data-ts=\"1552409092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441921-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers: </strong>VivoPower International (NASDAQ:<a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a>) <font color=\"green\">+52%</font>. ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>) <font color=\"green\">+41%</font>. Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a>) <font color=\"green\">+31%</font>. Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) <font color=\"green\">+30%</font>. Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"green\">+26%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+24%</font>. Chaparral Energy (NYSE:<a href='https://seekingalpha.com/symbol/CHAP' title='Chaparral Energy, Inc.'>CHAP</a>) <font color=\"green\">+22%</font>. Jounce Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/JNCE' title='Jounce Therapeutics, Inc.'>JNCE</a>) <font color=\"green\">+23%</font>. Mersana Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRSN' title='Mersana Therapeutics, Inc.'>MRSN</a>) <font color=\"green\">+18%</font>. Huttig Building Products (NASDAQ:<a href='https://seekingalpha.com/symbol/HBP' title='Huttig Building Products, Inc.'>HBP</a>) <font color=\"green\">+15%</font>.</li> <li><strong>Losers: </strong>Zafgen (NASDAQ:<a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a>) <font color=\"red\">-35%</font>. Valhi (NYSE:<a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a>) <font color=\"red\">-27%</font>. Globus Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Limited'>GLBS</a>) <font color=\"red\">-20%</font>. B.O.S Better Online Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S Better Online Solutions Ltd.'>BOSC</a>) <font color=\"red\">-17%</font>. MDC Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/MDCA' title='MDC Partners Inc.'>MDCA</a>) <font color=\"red\">-15%</font>. Netshoes (Cayman) (NYSE:<a href='https://seekingalpha.com/symbol/NETS' title='Netshoes &#40;Cayman&#41; Limited'>NETS</a>) <font color=\"red\">-14%</font>. AgroFresh Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/AGFS' title='AgroFresh Solutions, Inc.'>AGFS</a>) <font color=\"red\">-13%</font>. ADT (NYSE:<a href='https://seekingalpha.com/symbol/ADT' title='ADT Inc.'>ADT</a>) <font color=\"red\">-12%</font>. Mistras Group (NYSE:<a href='https://seekingalpha.com/symbol/MG' title='Mistras Group, Inc.'>MG</a>) <font color=\"red\">-11%</font>. Inpixon (NASDAQ:<a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441921\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$VVPR $NDRA $LPTX - Microcaps mostly among midday movers https://seekingalpha.com/news/3441921-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441921-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441917\" data-ts=\"1552408863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441917-biotechs-mostly-in-green-on-sharpless-nod-to-head-fda\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biotechs (mostly) in the green on Sharpless nod to head FDA</a></h4><ul><li>Biotech investors appear to be comfortable with FDA Commissioner <a href=\"https://seekingalpha.com/news/3441914-nci-director-sharpless-head-fda\" target=\"_blank\">designee</a> Norman Sharpless who has run the NCI since 2017.</li><li>Selected tickers: Ionis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color=\"green\">+0.7%</font>), Incyte (<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color=\"green\">+0.8%</font>), Intrexon (<a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corporation'>XON</a> <font color=\"green\">+3.4%</font>), CRISPR Therapeutics (<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a> <font color=\"green\">+1.4%</font>), Editas Medicine (<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine, Inc.'>EDIT</a> <font color=\"green\">+2.6%</font>), Intellia Therapeutics (<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics, Inc.'>NTLA</a> <font color=\"green\">+1.3%</font>), bluebird bio (<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color=\"red\">-0.5%</font>), BioMarin Pharmaceutical (<a href='https://seekingalpha.com/symbol/BMRN' title='BioMarin Pharmaceutical Inc.'>BMRN</a> <font color=\"green\">+1.4%</font>), Vertex Pharmaceuticals (<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color=\"green\">+1.1%</font>), Amgen (<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>), Gilead Sciences (<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"green\">+0.7%</font>), Biogen (<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color=\"green\">+0.7%</font>), Galapagos N.V. (<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos NV'>GLPG</a> <font color=\"red\">-0.5%</font>), Alexion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color=\"green\">+1.6%</font>), Alnylam Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color=\"green\">+0.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441917\" data-linked=\"Biotechs (mostly) in the green on Sharpless nod to head FDA\" data-tweet=\"$IONS $INCY $XON - Biotechs (mostly) in the green on Sharpless nod to head FDA https://seekingalpha.com/news/3441917-biotechs-mostly-in-green-on-sharpless-nod-to-head-fda?source=tweet\" data-url=\"https://seekingalpha.com/news/3441917-biotechs-mostly-in-green-on-sharpless-nod-to-head-fda\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441910\" data-ts=\"1552407937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFMD\" target=\"_blank\">AFMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441910-affimed-up-14-ahead-of-afm11-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Affimed up 14% ahead of AFM11 update</a></h4><ul><li>Affimed N.V. (<a href='https://seekingalpha.com/symbol/AFMD' title='Affimed N.V.'>AFMD</a> <font color=\"green\">+13.5%</font>) is up on a 4x surge in volume clearing a two-month base. No readily available news accounts for the action but the company has been working through the clinical hold on its AFM11 program. Five months ago, it <a href=\"https://seekingalpha.com/news/3395866-affimed-suspends-clinical-studies-blood-cancer-candidate-afm11-adverse-events\" target=\"_blank\">suspended </a>dosing and recruitment in two early-stage studies following three serious treatment-related adverse events, including one death, in patients receiving the highest dose in each trial. No serious adverse events were reported for the lower doses. The company says it will update investors after it completes the data analyses.</li><li>At the end of the month, abstracts on AFM24 and AFM13, both immune cell engagers, will be presented at AACR in Atlanta.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441910\" data-linked=\"Affimed up 14% ahead of AFM11 update\" data-tweet=\"$AFMD - Affimed up 14% ahead of AFM11 update https://seekingalpha.com/news/3441910-affimed-up-14-ahead-of-afm11-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3441910-affimed-up-14-ahead-of-afm11-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441913\" data-ts=\"1552407936\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCC\" target=\"_blank\">OCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441913-optical-cable-down-4-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Optical Cable down 4% post Q1 results</a></h4><ul><li>Optical Cable (<a href='https://seekingalpha.com/symbol/OCC' title='Optical Cable Corporation'>OCC</a> <font color=\"red\">-4.4%</font>) reported Q1 net sales of $16.75M (-4.6% Y/Y), reflecting $1.2M in net sales related to a military project during the first quarter of last year that did not recur this year.</li><li>Q1 Gross margin <font color=\"red\">declined by 852 bps</font> to 21.3%.</li><li>SG&amp;A expenses were $6.77M (+21.9% Y/Y), due to increase in employee related costs totaling $1.1M; and margin of 40.4% <font color=\"red\">up by 877 bps</font>.</li><li>Company\u2019s sales order backlog/forward load was $10M at the end of the quarter.</li><li>Company has cash in hand of $418k as of January 31, 2019.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441789-optical-cable-reports-q1-results\" target=\"_blank\">Optical Cable reports Q1 results</a> (March 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441913\" data-linked=\"Optical Cable down 4% post Q1 results\" data-tweet=\"$OCC - Optical Cable down 4% post Q1 results https://seekingalpha.com/news/3441913-optical-cable-down-4-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3441913-optical-cable-down-4-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441909\" data-ts=\"1552407718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YETI\" target=\"_blank\">YETI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441909-citi-confident-on-yetis-growth-track\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi confident on Yeti&#39;s growth track</a></h4><ul><li>Yeti (<a href='https://seekingalpha.com/symbol/YETI' title='YETI Holdings, Inc.'>YETI</a> <font color='green'>+0.6%</font>) gains slightly after Citi says it has \"great confidence\" in the company's growth targets for both 2019 and beyond.</li><li>Yeti's growing international exposure and slate of new products has the attention of the Citi analyst team.</li><li>Citi has a Buy rating on Yeti and price target of $27</li></ul><div class=\"tiny-share-widget\" data-id=\"3441909\" data-linked=\"Citi confident on Yeti&#39;s growth track\" data-tweet=\"$YETI - Citi confident on Yeti&#39;s growth track https://seekingalpha.com/news/3441909-citi-confident-on-yetis-growth-track?source=tweet\" data-url=\"https://seekingalpha.com/news/3441909-citi-confident-on-yetis-growth-track\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441911\" data-ts=\"1552407612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LL\" target=\"_blank\">LL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441911-lumber-liquidators-to-pay-33m-in-fines-restitution-in-settlement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lumber Liquidators to pay $33M in fines, restitution in settlement</a></h4><ul><li>Lumber Liquidators (<a href='https://seekingalpha.com/symbol/LL' title='Lumber Liquidators Holdings, Inc.'>LL</a> <font color=\"green\">+2%</font>) says it <a href=\"https://seekingalpha.com/pr/17441674-lumber-liquidators-resolves-matters-u-s-attorneys-office-doj-sec\" target=\"_blank\">agrees to pay</a> a $19.1M fine and $13.9M in restitution for making fraudulent misstatements to investors, in a settlement with the U.S. Attorney's Office, DoJ and SEC; shares trade higher after being halted.</li><li><a href=\"https://seekingalpha.com/pr/17441679-sec-charges-lumber-liquidators-fraud\" target=\"_blank\">The SEC says</a> the charges stem from LL's \"false public statements in  response to media allegations that the company was selling laminate  flooring that contained levels of formaldehyde exceeding regulatory  standards.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3441911\" data-linked=\"Lumber Liquidators to pay $33M in fines, restitution in settlement\" data-tweet=\"$LL - Lumber Liquidators to pay $33M in fines, restitution in settlement https://seekingalpha.com/news/3441911-lumber-liquidators-to-pay-33m-in-fines-restitution-in-settlement?source=tweet\" data-url=\"https://seekingalpha.com/news/3441911-lumber-liquidators-to-pay-33m-in-fines-restitution-in-settlement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441903\" data-ts=\"1552406731\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441903-telecom-italiaminus-4_7-board-tension-ratchets-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telecom Italia -4.7% as board tension ratchets up</a></h4><ul>   <li>Telecom Italia (<a href=\"http://seekingalpha.com/symbol/TI\" target=\"_blank\">TI</a> <font color=\"red\">-4.7%</font>) has tumbled today amid ongoing tension in the battle for the company's board.</li>    <li>An annual general meeting coming at the end of the month presents high stakes again, after Elliott Management wrested control of the board last spring from top shareholder Vivendi (<a href=\"http://seekingalpha.com/symbol/VIVHY\" target=\"_blank\">VIVHY</a> <font color=\"green\">+0.3%</font>).</li>    <li>Since then, shares have declined, and Vivendi has been sharply critical of Elliott's approach and is now pressing to replace five Elliott-backed boardmembers.</li>    <li>Proxy adviser Institutional Shareholder Services is recommending a vote against Vivendi, Bloomberg reports.</li>    <li>\"Vivendi hasn\u2019t presented a substantive argument related to performance beyond noting the significant stock price decline since last year\u2019s AGM,\u201d ISS says, adding that the governance track record of Vivendi's controlling shareholder, Bollore (<a href=\"http://seekingalpha.com/symbol/BOIVF\" target=\"_blank\">BOIVF</a> <font color=\"green\">+1.4%</font>), is \"far from ideal\" and \"far below French market standards.\"</li>    <li>Vivendi's past actions undermine moral authority in this case, ISS adds, and stock underperformance may be due more to a hot competitive environment and expensive spectrum auction.</li>    <li>Meanwhile, UBS says \"the only way forward\" is some kind of compromise between Vivendi and Elliott.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441903\" data-linked=\"Telecom Italia -4.7% as board tension ratchets up\" data-tweet=\"$TI $VIVHY $BOIVF - Telecom Italia -4.7% as board tension ratchets up https://seekingalpha.com/news/3441903-telecom-italiaminus-4_7-board-tension-ratchets-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3441903-telecom-italiaminus-4_7-board-tension-ratchets-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441902\" data-ts=\"1552406726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRTS\" target=\"_blank\">RRTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441902-roadrunner-transportation-down-14-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roadrunner Transportation down 14% post Q4 results</a></h4><ul><li>Roadrunner Transportation Systems (<a href='https://seekingalpha.com/symbol/RRTS' title='Roadrunner Transportation Systems, Inc.'>RRTS</a> <font color=\"red\">-14.5%</font>) reported Q4 revenue of $551.5M a decline of 1.6% Y/Y, Ascent Global Logistics revenue increased by 12.6% Y/Y, but were offset by declines in the Truckload &amp; Express Services and Less-Than-Truckload segments.</li><li>Adj. EBITDA was $2.94M for the quarter, compared to a loss of $3.05M same quarter last year.</li><li>Segment Adj. EBITDA: TES $10.63M (-15.4% Y/Y); LTL negative $8.26M compared to negative $10.71M a year ago; and Ascent $8.48M (+15.9% Y/Y).</li><li>Net cash provided by operating activities YTD was $5.59M, compared to $45.55M used a year ago.</li><li>Company has Cash and cash equivalents of $11.18M, as of December 31, 2018.</li><li>Company expects to increase its Adjusted EBITDA in 2019 with improvements in all three segments.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441735-roadrunner-transportation-misses-revenue\" target=\"_blank\">Roadrunner Transportation misses on revenue</a> (March 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3441902\" data-linked=\"Roadrunner Transportation down 14% post Q4 results\" data-tweet=\"$RRTS - Roadrunner Transportation down 14% post Q4 results https://seekingalpha.com/news/3441902-roadrunner-transportation-down-14-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3441902-roadrunner-transportation-down-14-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441899\" data-ts=\"1552406363\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441899-orchids-paper-products-only-consumer-gainer-seneca-foods-and-sunopta-in-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orchids Paper Products only consumer gainer; Seneca Foods and SunOpta in losers</a></h4><ul><li><b>Gainers: </b>Orchids Paper Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/TIS' title='Orchids Paper Products Company'>TIS</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Seneca Foods (NASDAQ:<a href='https://seekingalpha.com/symbol/SENEA' title='Seneca Foods Corporation'>SENEA</a>) <font color=\"red\">-6%</font>. SunOpta (NASDAQ:<a href='https://seekingalpha.com/symbol/STKL' title='SunOpta Inc.'>STKL</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441899\" data-linked=\"Orchids Paper Products only consumer gainer; Seneca Foods and SunOpta in losers\" data-tweet=\"$TIS $SENEA $STKL - Orchids Paper Products only consumer gainer; Seneca Foods and SunOpta in losers https://seekingalpha.com/news/3441899-orchids-paper-products-only-consumer-gainer-seneca-foods-and-sunopta-in-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441899-orchids-paper-products-only-consumer-gainer-seneca-foods-and-sunopta-in-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441893\" data-ts=\"1552404580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLO\" target=\"_blank\">SHLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441893-shiloh-industriesplus-3-post-q1-results-reaffirms-fy19-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shiloh Industries +3% post Q1 results, reaffirms FY19 guidance</a></h4><div><ul><li>Shiloh Industries (<a href='https://seekingalpha.com/symbol/SHLO' title='Shiloh Industries, Inc.'>SHLO</a> <font color=\"green\">+3.4%</font>) reported Q1 revenue growth of 4.5% Y/Y to $258.7M; and gross profit of $13.69M (-50.9% Y/Y).</li><li>Q4 Gross margin <font color=\"red\">declined by 597 bps</font> to 5.3%.</li><li>Adj. EBITDA of $12.61M (-23.9% Y/Y) and margin of 4.9% <font color=\"red\">down by 182 bps</font>.</li><li>SG&amp;A expenses were $16.08M (-24.3% Y/Y) and margin <font color=\"green\">declined by 236 bps</font> to 6.2%.</li><li>Net cash provided by operating activities YTD was $6.36M, compared to $11.64M a year ago.</li><li>Company had Cash and cash equivalents at end of period of $11.67M, as of December 31, 2018.</li><li>FY19 Outlook, reaffirmed: Revenue $1B to $1.15B; Adj. EBITDA $62M to $70M; and expects Capex to be ~4%-5% of revenue.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441754-shiloh-beats-0_11-misses-revenue\" target=\"_blank\">Shiloh beats by $0.11, misses on revenue</a> (March 12)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3441893\" data-linked=\"Shiloh Industries +3% post Q1 results, reaffirms FY19 guidance\" data-tweet=\"$SHLO - Shiloh Industries +3% post Q1 results, reaffirms FY19 guidance https://seekingalpha.com/news/3441893-shiloh-industriesplus-3-post-q1-results-reaffirms-fy19-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3441893-shiloh-industriesplus-3-post-q1-results-reaffirms-fy19-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441889\" data-ts=\"1552403721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441889-private-label-move-dicks-sends-jolt-through-athletic-apparel-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Private label move by Dick&#39;s sends a jolt through athletic apparel sector</a></h4><ul><li>Shares of Under Armour (<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a> <font color='red'>-3%</font>), Lululemon (<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='red'>-1.8%</font>), Nike (<a href='https://seekingalpha.com/symbol/NKE' title='NIKE, Inc.'>NKE</a> <font color='red'>-0.8%</font>) and Adidas (<a href='https://seekingalpha.com/symbol/ADDYY' title='adidas AG'>OTCQX:ADDYY</a> <font color='red'>-1.4%</font>) trade lower after Dick's Sporting Goods (<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a> <font color='red'>-12.1%</font>) drops a licensing deal with Reebok in order to relaunch one of the company's own private labels. </li></ul><div class=\"tiny-share-widget\" data-id=\"3441889\" data-linked=\"Private label move by Dick&#39;s sends a jolt through athletic apparel sector\" data-tweet=\"$UAA $LULU $NKE - Private label move by Dick&#39;s sends a jolt through athletic apparel sector https://seekingalpha.com/news/3441889-private-label-move-dicks-sends-jolt-through-athletic-apparel-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3441889-private-label-move-dicks-sends-jolt-through-athletic-apparel-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441885\" data-ts=\"1552403023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441885-seelos-therapeutics-and-bio-path-holdings-among-healthcare-gainers-nuvasive-and-zafgen-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seelos Therapeutics and Bio-Path Holdings among healthcare gainers; NuVasive and Zafgen among the losers</a></h4><ul><li><b>Gainers: </b>ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>) <font color=\"green\">+30%</font>. Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"green\">+21%</font>. Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a>) <font color=\"green\">+17%</font>. Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+16%</font>. Jounce Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/JNCE' title='Jounce Therapeutics, Inc.'>JNCE</a>) <font color=\"green\">+16%</font>.</li><li><b>Losers: </b>Zafgen (NASDAQ:<a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a>) <font color=\"red\">-35%</font>. Crinetics Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CRNX' title='Crinetics Pharmaceuticals, Inc.'>CRNX</a>) <font color=\"red\">-13%</font>. NanoString Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/NSTG' title='NanoString Technologies, Inc.'>NSTG</a>) <font color=\"red\">-8%</font>. NuVasive (NASDAQ:<a href='https://seekingalpha.com/symbol/NUVA' title='NuVasive, Inc.'>NUVA</a>) <font color=\"red\">-8%</font>. Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441885\" data-linked=\"Seelos Therapeutics and Bio-Path Holdings among healthcare gainers; NuVasive and Zafgen among the losers\" data-tweet=\"$NDRA $SEEL $LPTX - Seelos Therapeutics and Bio-Path Holdings among healthcare gainers; NuVasive and Zafgen among the losers https://seekingalpha.com/news/3441885-seelos-therapeutics-and-bio-path-holdings-among-healthcare-gainers-nuvasive-and-zafgen-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3441885-seelos-therapeutics-and-bio-path-holdings-among-healthcare-gainers-nuvasive-and-zafgen-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441880\" data-ts=\"1552402130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDCA\" target=\"_blank\">MDCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441880-mdc-partnersminus-12_6-bmo-frets-growth-turnaround\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MDC Partners -12.6% as BMO frets growth turnaround</a></h4><ul>   <li>MDC Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/MDCA' title='MDC Partners Inc.'>MDCA</a>) has <font color=\"red\">tumbled 12.6%</font> today after a cut to Market Perform by BMO, now less confident that the company can turn its business around.</li>    <li>The company's faced challenging activity in its accounts, Daniel Salmon writes, which is weakening confidence in near-term organic growth.</li>    <li>He's halved his price target for the company to $2.50 from $5, vs. yesterday's close of $2.46; after today's decline, the target implies 16% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441880\" data-linked=\"MDC Partners -12.6% as BMO frets growth turnaround\" data-tweet=\"$MDCA - MDC Partners -12.6% as BMO frets growth turnaround https://seekingalpha.com/news/3441880-mdc-partnersminus-12_6-bmo-frets-growth-turnaround?source=tweet\" data-url=\"https://seekingalpha.com/news/3441880-mdc-partnersminus-12_6-bmo-frets-growth-turnaround\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441878\" data-ts=\"1552402015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPEX\" target=\"_blank\">SPEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441878-spherix-up-4-on-10-k-filing-7_5m-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spherix up 4% on 10-K filing, $7.5M gain</a></h4><ul><li>Thinly traded nano cap Spherix (<a href='https://seekingalpha.com/symbol/SPEX' title='Spherix Incorporated'>SPEX</a> <font color=\"green\">+3.5%</font>) is up, albeit on turnover of only 7,800 shares, following its <a href=\"https://seekingalpha.com/pr/17440925-spherix-announces-filing-annual-report-form-10-k-records-7_5-million-one-time-gain\" target=\"_blank\">announcement</a> that it has filed its 2018 annual report that included a $7.5M one-time gain in Q4.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441878\" data-linked=\"Spherix up 4% on 10-K filing, $7.5M gain\" data-tweet=\"$SPEX - Spherix up 4% on 10-K filing, $7.5M gain https://seekingalpha.com/news/3441878-spherix-up-4-on-10-k-filing-7_5m-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3441878-spherix-up-4-on-10-k-filing-7_5m-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441874\" data-ts=\"1552401747\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMRD\" target=\"_blank\">NMRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441874-nemaura-establishes-sugarbeat-distribution-in-middle-east-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nemaura establishes SugarBEAT distribution in Middle East; shares up 4%</a></h4><ul><li>Nemaura Medical (<a href='https://seekingalpha.com/symbol/NMRD' title='Nemaura Medical Inc.'>NMRD</a> <font color=\"green\">+3.9%</font>) inks an <a href=\"https://seekingalpha.com/pr/17441362-nemaura-medical-announces-exclusive-license-supply-agreement-sugarbeat-gcc-region\" target=\"_blank\">agreement</a> with medical device distributor TPMENA for continuous glucose monitor SugarBEAT in the Gulf Cooperation Council Region which includes Bahrain, Kuwait, Saudi Arabia, Oman and UAE.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441874\" data-linked=\"Nemaura establishes SugarBEAT distribution in Middle East; shares up 4%\" data-tweet=\"$NMRD - Nemaura establishes SugarBEAT distribution in Middle East; shares up 4% https://seekingalpha.com/news/3441874-nemaura-establishes-sugarbeat-distribution-in-middle-east-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3441874-nemaura-establishes-sugarbeat-distribution-in-middle-east-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441871\" data-ts=\"1552401255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TST\" target=\"_blank\">TST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441871-thestreetminus-1_8-after-revenues-dip-in-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TheStreet -1.8% after revenues dip in Q4</a></h4><ul>   <li>TheStreet (NASDAQ:<a href='https://seekingalpha.com/symbol/TST' title='TheStreet, Inc.'>TST</a>) is <font color=\"red\">1.8% lower</font> after its <a href=\"https://seekingalpha.com/news/3441746-thestreet-eps-0_06\" target=\"_blank\">Q4 earnings</a> this morning, where revenues dropped slightly year-over-year but largely met expectations.</li>    <li>Declines in its business-to-consumer business were mostly offset by gains in business-to-business. The company recently closed on a sale of the B2B business to Euromoney, and expects to distribute a substantial portion of those proceeds to shareholders.</li>    <li>Net loss from continuing operations was $3M, down from a prior-year profit of $3.5M mainly due to a $21.5M goodwill impairment of the B2C business (offset largely by a $21.3M tax benefit).</li>    <li>EBITDA was $2.4M.</li>    <li>Revenue breakout: Business to business, $6.7M (up 5.6%); Business to consumer, $7.2M (down 5.7%).</li>    <li>Cash and equivalents were up $25.5M Y/Y to $39.4M, mainly from the $28.2M sale of RateWatch along with cash from operations of $2.3M.</li>    <li><a href=\"https://seekingalpha.com/pr/17440665-thestreet-reports-fourth-quarter-full-year-2018-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3441871\" data-linked=\"TheStreet -1.8% after revenues dip in Q4\" data-tweet=\"$TST - TheStreet -1.8% after revenues dip in Q4 https://seekingalpha.com/news/3441871-thestreetminus-1_8-after-revenues-dip-in-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3441871-thestreetminus-1_8-after-revenues-dip-in-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441869\" data-ts=\"1552400767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCB\" target=\"_blank\">ARCB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441869-arcbest-falls-after-bofa-merrill-lynch-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcBest falls after BofA Merrill Lynch warning</a></h4><ul> <li>ArcBest (<a href='https://seekingalpha.com/symbol/ARCB' title='ArcBest Corporation'>ARCB</a> <font color='red'>-2.8%</font>) trades lower after a biting update from Bank of America Merrill Lynch.</li> <li>BAML sees ArcBest's fixed cost base as a continued headwind to meaningful margin improvement if freight activity is to remain subdued.</li> <li>\"We anticipate a 300 bp deterioration in 1Q19 Freight margins from 4Q18 and await evidence that ARCB can improve margins despite a softer freight market,\" updates the analyst team.</li> <li>Shares of ArcBest are rated by BAML at Underweight and assigned a price objective of $34.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441869\" data-linked=\"ArcBest falls after BofA Merrill Lynch warning\" data-tweet=\"$ARCB - ArcBest falls after BofA Merrill Lynch warning https://seekingalpha.com/news/3441869-arcbest-falls-after-bofa-merrill-lynch-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3441869-arcbest-falls-after-bofa-merrill-lynch-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441866\" data-ts=\"1552400370\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUVA\" target=\"_blank\">NUVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441866-nuvasive-down-7-on-smith-nephew-takeout-of-osiris\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NuVasive down 7% on Smith &amp; Nephew takeout of Osiris</a></h4><ul><li>NuVasive (<a href='https://seekingalpha.com/symbol/NUVA' title='NuVasive, Inc.'>NUVA</a> <font color=\"red\">-7.1%</font>) slips on modestly higher volume on the heels of Smith &amp; Nephew's (<a href='https://seekingalpha.com/symbol/SNN' title='Smith & Nephew plc'>SNN</a> <font color=\"green\">+0.4%</font>) <a href=\"https://seekingalpha.com/news/3441839-smith-and-nephew-acquire-osiris-therapeutics-660m\" target=\"_blank\">$661M bid</a> for Osiris Therapeutics, appearing to dash <a href=\"https://seekingalpha.com/news/3431624-smith-and-nephew-nuvasive-go-opposite-ways-potential-tie\" target=\"_blank\">rumors </a>of a NUVA/SNN tie-up.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441866\" data-linked=\"NuVasive down 7% on Smith &amp; Nephew takeout of Osiris\" data-tweet=\"$NUVA $SNN - NuVasive down 7% on Smith &amp; Nephew takeout of Osiris https://seekingalpha.com/news/3441866-nuvasive-down-7-on-smith-nephew-takeout-of-osiris?source=tweet\" data-url=\"https://seekingalpha.com/news/3441866-nuvasive-down-7-on-smith-nephew-takeout-of-osiris\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441863\" data-ts=\"1552400075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441863-airline-stocks-dragged-down-boeing-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Airline stocks dragged down by Boeing focus</a></h4><ul> <li>Airline stocks open weak again as the threat of disruption over the Boeing 737 Max 8 groundings internationally weigh over the sector. Before the Max 8 crash over the weekend, some safety concerns were already being raised by mechanics over working conditions. Then today, even President Trump is chiming in by tweeting that \"airplanes are becoming far too complex\" to fly. Still, the selling pressure arrives with the commercial safety record in the U.S. very strong compared to other parts of the world.</li> <li>Decliners include Alaska Air Group (<a href='https://seekingalpha.com/symbol/ALK' title='Alaska Air Group, Inc.'>ALK</a> <font color='red'>-2.7%</font>), Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color='red'>-2.6%</font>), Hawaiian Holdings (<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a> <font color='red'>-1.1%</font>), Allegiant Travel (<a href='https://seekingalpha.com/symbol/ALGT' title='Allegiant Travel Company'>ALGT</a> <font color='red'>-1.3%</font>), SkyWest (<a href='https://seekingalpha.com/symbol/SKYW' title='SkyWest, Inc.'>SKYW</a> <font color='red'>-0.9%</font>), Mesa Air (<a href='https://seekingalpha.com/symbol/MESA' title='Mesa Air Group, Inc.'>MESA</a> <font color='red'>-1.7%</font>), United Continental (<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc.'>UAL</a> <font color='red'>-2.5%</font>), Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='red'>-1.3%</font>) and Spirit Airlines (<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines, Inc.'>SAVE</a> <font color='red'>-1.1%</font>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3441863\" data-linked=\"Airline stocks dragged down by Boeing focus\" data-tweet=\"$ALK $LUV $HA - Airline stocks dragged down by Boeing focus https://seekingalpha.com/news/3441863-airline-stocks-dragged-down-boeing-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/3441863-airline-stocks-dragged-down-boeing-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441862\" data-ts=\"1552399996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441862-starboard-looking-hedge-fund-tactic-to-tip-vote-in-favor-of-bristol-myers-celgene-tie-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starboard &quot;looking into&quot; hedge fund tactic to tip vote in favor of Bristol-Myers/Celgene tie-up</a></h4><ul><li>Activist investor Starboard Value, an opponent of Bristol-Myers Squibb's (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.5%</font>) $74B takeout of Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color=\"red\">-0.1%</font>), is <a href=\"https://nypost.com/2019/03/11/investor-thinks-hedge-funds-are-influencing-74b-pharma-deal/\" target=\"_blank\">investigating </a>whether hedge funds are using a controversial stock-trading tactic to sway the vote in favor of the deal, turning their long positions in Celgene into big winners.</li><li>The tactic, called \"empty voting,\" involves buying shares strictly for voting purposes, then selling them afterward.</li><li>Dan Loeb's Third Point and D.E. Shaw are mentioned as possible participants but this is unconfirmed.</li><li>Shareholders will vote on the merger in a few weeks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441862\" data-linked=\"Starboard &quot;looking into&quot; hedge fund tactic to tip vote in favor of Bristol-Myers/Celgene tie-up\" data-tweet=\"$BMY $CELG - Starboard &quot;looking into&quot; hedge fund tactic to tip vote in favor of Bristol-Myers/Celgene tie-up https://seekingalpha.com/news/3441862-starboard-looking-hedge-fund-tactic-to-tip-vote-in-favor-of-bristol-myers-celgene-tie-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3441862-starboard-looking-hedge-fund-tactic-to-tip-vote-in-favor-of-bristol-myers-celgene-tie-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441861\" data-ts=\"1552399927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOMO\" target=\"_blank\">MOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441861-momoplus-13-after-q4-revenue-rise-50\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Momo +13% after Q4 revenue rise 50%</a></h4><ul>   <li>Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo Inc.'>MOMO</a>) has <font color=\"green\">jumped 13.3%</font> out of today's open on Nasdaq after topping expectations with its Q4 earnings on 50% revenue growth and adjusted profits that jumped 22%.</li>    <li>Attributable net income (non-GAAP) rose to 887.4M yuan (about $129.1M) from 727.4M yuan.</li>    <li>Revenue rose 50% Y/Y to 3.84B yuan.</li>    <li>Operating income was 789.6M yuan (about $114.8M); aside from the healthy revenue gains, it was aided by other operating income that rose to 141.4M yuan from 92.6M, largely due to more government incentives.</li>    <li>In operating metrics, monthly active users rose to 113.3M from the prior-year 99.1M.</li>    <li>Paying users of live video and value-added service (without double-counting overlap) was 13M, up from a previous 7.8M. That figure includes 3.9M paying users of Tantan limited.</li>    <li>Net revenue breakout: Live video service, 2.96B yuan (up 36.4%); Value-added service, 722.4M yuan (up 272%); Mobile marketing, 122.1M yuan (down 15.4%); Mobile games, 25.5M yuan (down 44%); other services, 14.6M yuan (up 750%).</li>    <li>For Q1, it's guiding to revenues of 3.55B-3.65B yuan (up 28-32% Y/Y in constant currency).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441727-momo-beats-0_07-beats-revenue\" target=\"_blank\">Momo beats by $0.07, beats on revenue</a> (Mar. 12 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17440580-momo-announces-unaudited-financial-results-fourth-quarter-fiscal-year-2018\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3441861\" data-linked=\"Momo +13% after Q4 revenue rise 50%\" data-tweet=\"$MOMO - Momo +13% after Q4 revenue rise 50% https://seekingalpha.com/news/3441861-momoplus-13-after-q4-revenue-rise-50?source=tweet\" data-url=\"https://seekingalpha.com/news/3441861-momoplus-13-after-q4-revenue-rise-50\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441857\" data-ts=\"1552399408\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWARF\" target=\"_blank\">NWARF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441857-norwegian-airminus-8-after-grounding-boeing-737-max-8s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Norwegian Air -8% after grounding Boeing 737 Max 8s</a></h4><ul> <li>Norwegian Air Shuttle (<a href='https://seekingalpha.com/symbol/NWARF' title='Norwegian Air Shuttle ASA'>OTCPK:NWARF</a>) is <font color=\"red\">down 8.2%</font> in Oslo trading after the airline grounds its Boeing 737 Max 8s.</li> <li>The company has 18 MAX jets in its fleet of 164 aircraft at the end of 2018 and is scheduled to take delivery on dozens more in the upcoming years.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3441857\" data-linked=\"Norwegian Air -8% after grounding Boeing 737 Max 8s\" data-tweet=\"$NWARF - Norwegian Air -8% after grounding Boeing 737 Max 8s https://seekingalpha.com/news/3441857-norwegian-airminus-8-after-grounding-boeing-737-max-8s?source=tweet\" data-url=\"https://seekingalpha.com/news/3441857-norwegian-airminus-8-after-grounding-boeing-737-max-8s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441847\" data-ts=\"1552398015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441847-boeing-737-max-8-planes-banned-from-uk-airspace-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing 737 Max 8 planes banned from UK airspace - CNBC</a></h4><ul><li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color=\"red\">-3%</font>) opens sharply lower following news that the UK Civil Aviation Authority has <a href=\"https://www.cnbc.com/2019/03/12/uk-has-grounded-all-boeing-737-max-aircraft.html\" target=\"_blank\">grounded 737 MAX planes</a>  following the second deadly crash of the model in less  than five months, CNBC reports.</li><li>The UK authority says \"as a precautionary measure, [it] issued instructions to stop any commercial  passenger flights from any operator arriving, departing or overflying UK  airspace.\"</li><li>Singapore and Australia announced overnight that they were <a href=\"https://seekingalpha.com/news/3441724-ba-minus-1_7-percent-singapore-australia-suspend-737-max-8-flights\" target=\"_blank\">suspending</a> 737 MAX flights, as well as  Mexico's Aeromexico, Brazil's Gol Transportes Aéreos and Argentina's  Aerolineas Argentinas.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441847\" data-linked=\"Boeing 737 Max 8 planes banned from UK airspace - CNBC\" data-tweet=\"$BA - Boeing 737 Max 8 planes banned from UK airspace - CNBC https://seekingalpha.com/news/3441847-boeing-737-max-8-planes-banned-from-uk-airspace-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/3441847-boeing-737-max-8-planes-banned-from-uk-airspace-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441846\" data-ts=\"1552398012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441846-neovasc-to-exchange-warrants-for-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc to exchange warrants for shares</a></h4><ul><li>Taking additional steps to windup the remnants of its 2017 financings, Neovasc (<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a> <font color=\"green\">+7.5%</font>) has <a href=\"https://seekingalpha.com/pr/17441354-neovasc-announces-agreements-exchange-outstanding-warrants-shares\" target=\"_blank\">agreed to issue</a> ~496K common shares in exchange for all of the ~58.4M outstanding warrants issued in 2017. The transactions should be completed by next week.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441846\" data-linked=\"Neovasc to exchange warrants for shares\" data-tweet=\"$NVCN - Neovasc to exchange warrants for shares https://seekingalpha.com/news/3441846-neovasc-to-exchange-warrants-for-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3441846-neovasc-to-exchange-warrants-for-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441843\" data-ts=\"1552397390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FFIV\" target=\"_blank\">FFIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441843-f5-networksminus-4_9-analysts-eyeball-nginx-purchase-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">F5 Networks -4.9% as analysts eyeball Nginx purchase deal</a></h4><ul>   <li>F5 Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/FFIV' title='F5 Networks, Inc.'>FFIV</a>) is <font color=\"red\">4.9% lower</font> premarket after yesterday's post-close announcement that it's <a href=\"https://seekingalpha.com/news/3441642-f5-acquire-nginx-670m-enterprise-value\" target=\"_blank\">acquiring Nginx</a> for an enterprise value of $670M, to some skepticism from analysts.</li>    <li>JPMorgan downgraded FFIV to Neutral from Overweight, saying the deal sets the bar \"quite high in terms of delivering on growth and revenue synergies\" as it changes a favorable position as a value investment to a challenging position as a growth stock. It substitutes execution risk on organic development with execution risk on integration and growth, a tougher swallow. (h/t Bloomberg)</li>    <li>JPMorgan cut its price target to $183 from $210, but bearish Deutsche Bank cut its target to a Street-low $110 after the deal, implying 32% downside.</li><li>Oppenheimer's more positive on the deal, but also notes heavy execution challenges and is staying Neutral until some of those risks are mitigated.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441843\" data-linked=\"F5 Networks -4.9% as analysts eyeball Nginx purchase deal\" data-tweet=\"$FFIV - F5 Networks -4.9% as analysts eyeball Nginx purchase deal https://seekingalpha.com/news/3441843-f5-networksminus-4_9-analysts-eyeball-nginx-purchase-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3441843-f5-networksminus-4_9-analysts-eyeball-nginx-purchase-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441842\" data-ts=\"1552397283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPTH\" target=\"_blank\">BPTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441842-bio-path-launches-stock-offering-shares-down-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bio-Path launches stock offering; shares down 8% premarket</a></h4><ul><li>On cue, Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <a href=\"https://seekingalpha.com/pr/17441349-bio-path-holdings-inc-announces-18_5-million-registered-direct-offering-common-stock\" target=\"_blank\">initiates </a>a direct offering of 712,910 shares of its common stock at $25.95 per share to institutional investors. Closing date is March 14.</li><li>Shares rocketed last week after the company <a href=\"https://seekingalpha.com/news/3440815-bio-path-174-percent-prexigebersen-data\" target=\"_blank\">reported </a>positive data on prexigebersen.</li><li>Shares are down <font color=\"red\">8%</font> premarket on robust volume after being up ~<font color=\"green\">20%</font>.</li><li>Yesterday's closing price was $32.44.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441842\" data-linked=\"Bio-Path launches stock offering; shares down 8% premarket\" data-tweet=\"$BPTH - Bio-Path launches stock offering; shares down 8% premarket https://seekingalpha.com/news/3441842-bio-path-launches-stock-offering-shares-down-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3441842-bio-path-launches-stock-offering-shares-down-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441839\" data-ts=\"1552397001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNN\" target=\"_blank\">SNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441839-smith-nephew-to-acquire-osiris-therapeutics-for-660m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smith &amp; Nephew to acquire Osiris Therapeutics for $660M</a></h4><ul><li>Smith &amp; Nephew (NYSE:<a href='https://seekingalpha.com/symbol/SNN' title='Smith & Nephew plc'>SNN</a>) has <a href=\"https://seekingalpha.com/pr/17441294-osiris-therapeutics-inc-enters-agreement-acquired-smith-and-nephew-plc\" target=\"_blank\">agreed to acquire</a> Osiris Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OSIR' title='Osiris Therapeutics, Inc.'>OSIR</a>) for $19 per share in cash representing a total transaction value of ~$660.5M. The deal should close next quarter.</li><li>OSIR closed yesterday at $18.88.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441839\" data-linked=\"Smith &amp; Nephew to acquire Osiris Therapeutics for $660M\" data-tweet=\"$SNN $OSIR - Smith &amp; Nephew to acquire Osiris Therapeutics for $660M https://seekingalpha.com/news/3441839-smith-nephew-to-acquire-osiris-therapeutics-for-660m?source=tweet\" data-url=\"https://seekingalpha.com/news/3441839-smith-nephew-to-acquire-osiris-therapeutics-for-660m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441838\" data-ts=\"1552396885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441838-stitch-fixplus-26-wall-street-firms-hike-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stitch Fix +26% as Wall Street firms hike targets</a></h4><ul> <li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) is on pace to open at its highest level of the year after the retailer's Q4 earnings report is viewed favorably by investors and analysts.</li> <li>Price target increases are rolling in from investment firms, including hikes from JPMorgan (to $30), SunTrust (to $43), Piper Jaffray (to $28), KeyBanc (to $40), Goldman Sachs (to $34).</li> <li>Shares of Stitch Fix is <font color=\"green\">up 25.88%</font> premarket to $34.00 in a rally that could have some shorts scrambling for the exit doors.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441605-stitch-fix-beats-0_07-beats-revenue\" target=\"_blank\">Stitch Fix beats by $0.07, beats on revenue</a> (March 11)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441611-stitch-fixplus-7-percent-ebitda-dazzles\" target=\"_blank\">Stitch Fix+7% after EBITDA dazzles</a> (March 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441838\" data-linked=\"Stitch Fix +26% as Wall Street firms hike targets\" data-tweet=\"$SFIX - Stitch Fix +26% as Wall Street firms hike targets https://seekingalpha.com/news/3441838-stitch-fixplus-26-wall-street-firms-hike-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/3441838-stitch-fixplus-26-wall-street-firms-hike-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441837\" data-ts=\"1552396852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPE\" target=\"_blank\">HPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441837-hp-enterpriseminus-4-ubs-downgrades-on-server-sales-struggles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HP Enterprise -4% as UBS downgrades on server-sales struggles</a></h4><ul>   <li>HP Enterprise (NYSE:<a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise Company'>HPE</a>) is <font color=\"red\">4% lower</font> premarket after a cut to Sell at UBS, from Neutral.</li>    <li>Growth in the cloud is likely to turn into a \"bigger headwind\" to on-premises hardware sales as it moves up from a 20% share, the firm says, and \"the 15%-plus (average selling price) growth is unlikely to repeat as component prices decline.\" It sees a 2% decline in server sales for fiscal 2019. (h/t Bloomberg)</li>    <li>UBS trimmed 2019 earnings estimates and cut its target price to a Street-low $13 from $17, implying 18% downside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441837\" data-linked=\"HP Enterprise -4% as UBS downgrades on server-sales struggles\" data-tweet=\"$HPE - HP Enterprise -4% as UBS downgrades on server-sales struggles https://seekingalpha.com/news/3441837-hp-enterpriseminus-4-ubs-downgrades-on-server-sales-struggles?source=tweet\" data-url=\"https://seekingalpha.com/news/3441837-hp-enterpriseminus-4-ubs-downgrades-on-server-sales-struggles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441833\" data-ts=\"1552396447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441833-nm-seel-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NM, SEEL among premarket gainers</a></h4><ul><li>Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) <font color=\"green\">+32%</font>.</li><li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) <font color=\"green\">+26%</font> on <a href=\"https://seekingalpha.com/news/3441605-stitch-fix-beats-0_07-beats-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li>Akebia Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKBA' title='Akebia Therapeutics, Inc.'>AKBA</a>) <font color=\"green\">+26%</font> on <a href=\"https://seekingalpha.com/news/3441769-akebia-38-percent-premarket-positive-vadadustat-data\" target=\"_blank\">positive</a> vadadustat data.</li><li>Lipocine (NASDAQ:<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a>) <font color=\"green\">+19%</font> on <a href=\"https://seekingalpha.com/news/3441801-lipocine-29-percent-premarket-positive-data-nash-candidate-lpcn-1144\" target=\"_blank\">positive</a> data on NASH candidate LPCN 1144.</li><li>Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"green\">+20%</font>.</li><li>Organogenesis Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ORGO' title='Organogenesis Holdings Inc.'>ORGO</a>) <font color=\"green\">+16%</font> on <a href=\"https://seekingalpha.com/pr/17441223-organogenesis-holdings-inc-announces-renu-clinical-trial-results-aaos-2019-annual-meeting\" target=\"_blank\">announcing</a> that clinical trial results demonstrating the effectiveness of ReNu.</li><li>Navios Maritime Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NM' title='Navios Maritime Holdings Inc.'>NM</a>) <font color=\"green\">+16%</font>.</li><li>DropCar (NASDAQ:<a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a>) <font color=\"green\">+12%</font>.</li><li>ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>) <font color=\"green\">+11%</font> following business <a href=\"https://seekingalpha.com/news/3441784-endra-life-sciences-18-percent-premarket-following-business-update\" target=\"_blank\">update</a>.</li><li>Momo (NASDAQ:<a href='https://seekingalpha.com/symbol/MOMO' title='Momo Inc.'>MOMO</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/news/3441727-momo-beats-0_07-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Northern Oil and Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil and Gas, Inc.'>NOG</a>) <font color=\"green\">+8%</font> on <a href=\"https://seekingalpha.com/news/3441745-northern-oil-and-gas-beats-0_11-misses-oil-gas-sales\" target=\"_blank\">Q4 earnings</a>.</li><li>Torchlight Energy Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a>) <font color=\"green\">+8%</font>.</li><li>Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a>) <font color=\"green\">+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441833\" data-linked=\"NM, SEEL among premarket gainers\" data-tweet=\"$BPTH $SFIX $AKBA - NM, SEEL among premarket gainers https://seekingalpha.com/news/3441833-nm-seel-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441833-nm-seel-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441831\" data-ts=\"1552396323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441831-dks-and-adt-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DKS and ADT among premarket losers</a></h4><ul><li>Zafgen (NASDAQ:<a href='https://seekingalpha.com/symbol/ZFGN' title='Zafgen, Inc.'>ZFGN</a>) <font color=\"red\">-26%</font> on <a href=\"https://seekingalpha.com/news/3441671-zafgen-27-percent-hours-suspension-ind-zgnminus-1258\" target=\"_blank\">suspension</a> of IND for ZGN-1258.</li><li>Pyxis Tankers (NASDAQ:<a href='https://seekingalpha.com/symbol/PXS' title='Pyxis Tankers Inc.'>PXS</a>) <font color=\"red\">-12%</font>.</li><li>ADT (NYSE:<a href='https://seekingalpha.com/symbol/ADT' title='ADT Inc.'>ADT</a>) <font color=\"red\">-11%</font> on <a href=\"https://seekingalpha.com/news/3441607-adt-beats-0_01-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Tonix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-7%</font>.</li><li>Globus Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Limited'>GLBS</a>) <font color=\"red\">-9%</font>.</li><li>Dick's Sporting Goods (NYSE:<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3441776-dicks-sporting-goods-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>NuVasive (NASDAQ:<a href='https://seekingalpha.com/symbol/NUVA' title='NuVasive, Inc.'>NUVA</a>) <font color=\"red\">-8%</font>.</li><li>Cellect Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a>) <font color=\"red\">-6%</font>.</li><li>Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"red\">-7%</font>.</li><li>Tenax Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a>) <font color=\"red\">-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441831\" data-linked=\"DKS and ADT among premarket losers\" data-tweet=\"$ZFGN $PXS $ADT - DKS and ADT among premarket losers https://seekingalpha.com/news/3441831-dks-and-adt-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3441831-dks-and-adt-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441824\" data-ts=\"1552395689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGLS\" target=\"_blank\">TGLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441824-tecnoglass-to-offer-8m-shares-in-follow-on-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tecnoglass to offer 8M shares in follow-on offering</a></h4><ul><li>Tecnoglass (NASDAQ:<a href='https://seekingalpha.com/symbol/TGLS' title='Tecnoglass Inc.'>TGLS</a>) <font color=\"red\">-9.3%</font> pre-market after announcing a follow-on <a href=\"https://seekingalpha.com/pr/17440192-tecnoglass-announces-proposed-follow-offering-ordinary-shares\" target=\"_blank\">public offering</a> of 8M common shares, with an underwriters option to purchase up to an additional 1.2M shares.</li><li>TGLS says it plans to use the proceeds for  investments in growth capital expenditures including to purchase new  equipment, its Saint-Gobain joint venture and for working capital and  other general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441824\" data-linked=\"Tecnoglass to offer 8M shares in follow-on offering\" data-tweet=\"$TGLS - Tecnoglass to offer 8M shares in follow-on offering https://seekingalpha.com/news/3441824-tecnoglass-to-offer-8m-shares-in-follow-on-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3441824-tecnoglass-to-offer-8m-shares-in-follow-on-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441822\" data-ts=\"1552395564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSIR\" target=\"_blank\">OSIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441822-osiris-therapeutics-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Osiris Therapeutics shares halted pending news</a></h4><ul><li>Nasdaq has suspended trading in Osiris Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OSIR' title='Osiris Therapeutics, Inc.'>OSIR</a>) pending the release of news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441822\" data-linked=\"Osiris Therapeutics shares halted pending news\" data-tweet=\"$OSIR - Osiris Therapeutics shares halted pending news https://seekingalpha.com/news/3441822-osiris-therapeutics-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3441822-osiris-therapeutics-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441807\" data-ts=\"1552393886\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DFRG\" target=\"_blank\">DFRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441807-del-friscos-restaurant-group-gains-after-unexpected-profit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Del Frisco&#39;s Restaurant Group gains after unexpected profit</a></h4><ul> <li>Del Frisco's Restaurant Group (NASDAQ:<a href='https://seekingalpha.com/symbol/DFRG' title='Del Frisco&#39;s Restaurant Group, Inc.'>DFRG</a>) tracks higher in early trading after posting an unexpected profit in <a href=\"https://seekingalpha.com/pr/17440754-del-frisco-s-restaurant-group-inc-reports-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\">Q4</a> on an adjusted basis.</li> <li>Comparable restaurant sales increased 0.1% during the quarter and restaurant-level EBITDA* increased 7.0% to $24.9M.</li> <li>Looking ahead, Del Frisco's anticipates total comparable sales growth of 0% to 1.5% in FY19 and seven to eight restaurant openings. Adjusted EBITDA of $58M to $66M is anticipated.</li> <li>Shares of DFRG are <font color=\"green\">up 1.55%</font> in premarket trading to $8.12.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441807\" data-linked=\"Del Frisco&#39;s Restaurant Group gains after unexpected profit\" data-tweet=\"$DFRG - Del Frisco&#39;s Restaurant Group gains after unexpected profit https://seekingalpha.com/news/3441807-del-friscos-restaurant-group-gains-after-unexpected-profit?source=tweet\" data-url=\"https://seekingalpha.com/news/3441807-del-friscos-restaurant-group-gains-after-unexpected-profit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441803\" data-ts=\"1552393454\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441803-morgan-stanley-reels-in-expectations-on-tesla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley reels in expectations on Tesla</a></h4><ul> <li>Morgan Stanley warns that Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) may have hit an \"air pocket\" of demand that prompted the Model 3 price cut.</li> <li>Analyst Adam Jonas and team cut the Q1 Tesla deliveries forecast by 23% to factor in \"sluggish\" U.S. sales and potential impediments to international deliveries. \"We are not inclined to buy now as we don\u2019t believe we\u2019d be compensated for the amount of risk we\u2019re taking. The potential longer-term 'resolution' of the Tesla story as we approach nine years after its IPO may require a few more chapters to play out,\" writes Jonas.</li> <li>MS now sees 2019 EPS of $1.30 vs. $4.17 prior and 2020 EPS of $6.69 vs. $10.22 prior. The firm's new price target on Tesla is <a href=\"https://www.cnbc.com/2019/03/12/tesla-headed-for-demand-air-pocket-morgan-stanley-sees-10percent-downside.html\" target=\"_blank\">$260</a> vs. $283 prior.</li> <li>Shares of Tesla are <font color=\"red\">down 1.40%</font> in premarket trading to $286.36.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441803\" data-linked=\"Morgan Stanley reels in expectations on Tesla\" data-tweet=\"$TSLA - Morgan Stanley reels in expectations on Tesla https://seekingalpha.com/news/3441803-morgan-stanley-reels-in-expectations-on-tesla?source=tweet\" data-url=\"https://seekingalpha.com/news/3441803-morgan-stanley-reels-in-expectations-on-tesla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>391&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441801\" data-ts=\"1552393371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPCN\" target=\"_blank\">LPCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441801-lipocine-up-29-premarket-on-positive-data-on-nash-candidate-lpcn-1144\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lipocine up 29% premarket on positive data on NASH candidate LPCN 1144</a></h4><ul><li>Nano cap Lipocine (NASDAQ:<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a>) is up <font color=\"green\">29%</font> premarket on increased volume in response to <a href=\"https://www.sec.gov/Archives/edgar/data/1535955/000114420419013395/tv515982_ex99-1.htm\" target=\"_blank\">positive 16-week result</a>s from an open-label liver fat imaging study of NASH candidate LPCN 1144.</li><li>The study assessed the potential therapeutic benefit of LPCN 1144 via magnetic resonance imaging, proton density fat fraction (MRI-PDFF), a non-invasive quantitative biomarker of liver fat content, in 36 hypogonadal males. 34 were evaluable (had at least one post-baseline MRI-PDFF visit). 62% (n=21/34) had nonalcoholic fatty liver disease &#40;NAFLD&#41;, defined as at least 5% baseline liver fat.</li><li>48% (n=10/21) of NAFLD patients treated with LPCN 1144 showed NAFLD resolution (liver fat &lt;5%) at week 16 compared to 28% (n=6/21) at week 8. All subjects who showed NAFLD resolution experienced at least a 35% relative reduction in liver fat from baseline.</li><li>A Phase 2 trial is next up.</li><li>LPCN 1144 is an orally available prodrug of bioidentical testosterone.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441801\" data-linked=\"Lipocine up 29% premarket on positive data on NASH candidate LPCN 1144\" data-tweet=\"$LPCN - Lipocine up 29% premarket on positive data on NASH candidate LPCN 1144 https://seekingalpha.com/news/3441801-lipocine-up-29-premarket-on-positive-data-on-nash-candidate-lpcn-1144?source=tweet\" data-url=\"https://seekingalpha.com/news/3441801-lipocine-up-29-premarket-on-positive-data-on-nash-candidate-lpcn-1144\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441795\" data-ts=\"1552392683\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441795-barclays-warns-on-food-distributors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays warns on food distributors</a></h4><ul> <li>Barclays sees a \"race to the bottom\" in the food distributors space as companies scrap for market share.</li> <li>The intensifying competition between C&amp;W Wholesale, Supervalu and Spartan is seen hacking away at margins for the distributors.</li> <li>Barclays lowers SpartanNash and United Natural Foods to Underweight ratings from Equalweight. The price target on Spartan goes to $15 from $18 and the PT on United Natural Foods is lowered to $10 from $14.</li> <li>UNFI <font color=\"red\">-2.99%</font> premarket to $14.25. SPTN not active.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441795\" data-linked=\"Barclays warns on food distributors\" data-tweet=\"Barclays warns on food distributors https://seekingalpha.com/news/3441795-barclays-warns-on-food-distributors?source=tweet\" data-url=\"https://seekingalpha.com/news/3441795-barclays-warns-on-food-distributors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441791\" data-ts=\"1552392373\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNST\" target=\"_blank\">MNST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441791-monster-beverage-dips-after-bmo-capital-warns-on-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Monster Beverage dips after BMO Capital warns on valuation</a></h4><ul> <li>BMO Capital drops Monster Beverage (NASDAQ:<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corporation'>MNST</a>) to a Market Perform rating from Outperform on a <a href=\"https://www.cnbc.com/2019/03/12/calls-of-the-day-tesla-boeing-coca-cola-monster-beverage-eli-lilly.html\" target=\"_blank\">valuation call</a>.</li> <li>The firm thinks current valuation, both absolute (29X near-ter, P/E) and relative to peers may be as good as it gets given the cloudier growth outlook and dwindling likelihood of the long-hoped-for buyout of Monster by Coca-Cola. \"We see limited ability to meaningfully exceed expectations and justify an even higher valuation multiple, given unfavorable sales/product mix and emerging competition at home as well as disappointing margin progression abroad,\" reads the analyst note.</li> <li>Shares of Monster Beverage are <font color=\"red\">down 1.21%</font> in premarket trading to $60.45.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441791\" data-linked=\"Monster Beverage dips after BMO Capital warns on valuation\" data-tweet=\"$MNST - Monster Beverage dips after BMO Capital warns on valuation https://seekingalpha.com/news/3441791-monster-beverage-dips-after-bmo-capital-warns-on-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3441791-monster-beverage-dips-after-bmo-capital-warns-on-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441784\" data-ts=\"1552391165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDRA\" target=\"_blank\">NDRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441784-endra-life-sciences-up-18-premarket-following-business-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endra Life Sciences up 18% premarket following business update</a></h4><ul><li>Thinly traded nano cap ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>) is up <font color=\"green\">18%</font> premarket, albeit on only 639 shares, following its <a href=\"https://seekingalpha.com/pr/17440196-endra-life-sciences-reports-full-year-2018-financial-and-operational-results\" target=\"_blank\">2018 results</a> and business update released after the close yesterday.</li><li>Net loss was ($9.9M), operations consumed ($7.7M), cash balance at year-end was $6.5M.</li><li><strong>Key milestones for 2019</strong>:</li><li>File for CE Mark for TAEUS system, an ultrasound device used to assess fally liver disease, in H1. Controlled market launch in Europe mid-year. Partnering with GE Healthcare on commercialization in Europe.</li><li>Update on human study of TAEUS in the coming weeks.</li><li>Collaboration with Western University in Ontario exploring the use of artificial intelligence in computational tasks related to TAEUS imaging applications off to an \"exciting start.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3441784\" data-linked=\"Endra Life Sciences up 18% premarket following business update\" data-tweet=\"$NDRA - Endra Life Sciences up 18% premarket following business update https://seekingalpha.com/news/3441784-endra-life-sciences-up-18-premarket-following-business-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3441784-endra-life-sciences-up-18-premarket-following-business-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441782\" data-ts=\"1552391011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTT\" target=\"_blank\">OPTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441782-ocean-power-tech-soars-past-7-on-deal-offshore-oil-and-gas-operator\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Power Tech soars past $7 on deal with offshore oil and gas operator</a></h4><ul><li>Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"green\">+2,230%</font> pre-market to surpass $7/share - which would be the stock's highest price since September 2016 - after <a href=\"https://seekingalpha.com/pr/17440624-ocean-power-technologies-signs-master-service-contract-leading-offshore-oil-gas-operator\" target=\"_blank\">signing a master service contract</a> with \"a leading offshore oil and gas operator.\"</li><li>The company says the contract is its \"first with a U.S. oil and gas operator, opening the door for OPT to provide solutions into the Gulf of Mexico where we believe there exists significant need for cost-effective remote offshore power and communications.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3441782\" data-linked=\"Ocean Power Tech soars past $7 on deal with offshore oil and gas operator\" data-tweet=\"$OPTT - Ocean Power Tech soars past $7 on deal with offshore oil and gas operator https://seekingalpha.com/news/3441782-ocean-power-tech-soars-past-7-on-deal-offshore-oil-and-gas-operator?source=tweet\" data-url=\"https://seekingalpha.com/news/3441782-ocean-power-tech-soars-past-7-on-deal-offshore-oil-and-gas-operator\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441781\" data-ts=\"1552390899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DKS\" target=\"_blank\">DKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441781-dicks-sporting-goodsminus-2-after-comparable-sales-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dick&#39;s Sporting Goods -2% after comparable sales drop</a></h4><ul> <li>Dick's Sporting Goods (NYSE:<a href='https://seekingalpha.com/symbol/DKS' title='Dick&#39;s Sporting Goods, Inc.'>DKS</a>) reports comparable sales fell 3.7% in <a href=\"https://seekingalpha.com/pr/17440804-dicks-sporting-goods-reports-full-year-2018-earnings-per-diluted-share-3_24-near-high-end\" target=\"_blank\">Q4</a> to miss the consensus estimate for a 3.3% drop. Adjusting for a calendar shift, comp sales were down 2.2%. The retailers says comp sales gains were struck across key categories and double digit percentage increases in e-commerce and private brand sales were recorded.</li> <li>Gross profit was 28.9% of sales vs. 28.8% consensus and 29.0% a year ago. Net income was 3.79% of sales vs. 3.77% a year ago.</li> <li>Total inventory was up 6.6% at the end of the quarter on a planned increase tied to strategic investments to support key growth categories.</li> <li>Looking ahead, Dick's anticipates full-year consolidated same store sales growth of approximately flat to an increase of 2% and full-year EPS of $3.15 to $3.35 vs. $3.35 consensus.</li> <li>Shares of Dick's are <font color=\"red\">down 2.36%</font> in premarket trading to $38.00.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441776-dicks-sporting-goods-beats-revenue\" target=\"_blank\">Dick's Sporting Goods beats on revenue</a> (March 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3441781\" data-linked=\"Dick&#39;s Sporting Goods -2% after comparable sales drop\" data-tweet=\"$DKS - Dick&#39;s Sporting Goods -2% after comparable sales drop https://seekingalpha.com/news/3441781-dicks-sporting-goodsminus-2-after-comparable-sales-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3441781-dicks-sporting-goodsminus-2-after-comparable-sales-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441769\" data-ts=\"1552389985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKBA\" target=\"_blank\">AKBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441769-akebia-up-38-premarket-on-positive-vadadustat-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akebia up 38% premarket on positive vadadustat data</a></h4><ul><li>Akebia Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKBA' title='Akebia Therapeutics, Inc.'>AKBA</a>) is up <font color=\"green\">38%</font> premarket on light volume in response to <a href=\"https://seekingalpha.com/pr/17440573-akebia-therapeutics-announces-positive-top-line-results-two-pivotal-phase-3-studies\" target=\"_blank\">positive topline results</a> from two Phase 3 clinical trials evaluating vadadustat in Japanese patients with anemia due to chronic kidney disease &#40;CKD&#41;.</li><li>Both studies, one in hemodialysis-dependent participants and one in non-dialysis dependent participants, met their primary endpoints.</li><li>Results from two single-arm trials in peritoneal dialysis subjects and hemodialysis subjects also support the use of vadadustat in these populations.</li><li><a href=\"http://akebia.com/programs/akb-6548/\" target=\"_blank\">Vadadustat </a>is an inhibitor of hypoxia inducible factor &#40;HIF&#41;-prolyl hydroxylase, an enzyme that promotes the breakdown of HIF proteins. HIF is the primary regulator of the production of red blood cells. The body's natural response to anemia is to increase the level of HIF proteins.</li><li>The company will discuss the data during its Q4 and 2018 earnings call on Monday, March 18, at 4:30 pm ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441769\" data-linked=\"Akebia up 38% premarket on positive vadadustat data\" data-tweet=\"$AKBA - Akebia up 38% premarket on positive vadadustat data https://seekingalpha.com/news/3441769-akebia-up-38-premarket-on-positive-vadadustat-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3441769-akebia-up-38-premarket-on-positive-vadadustat-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441771\" data-ts=\"1552389684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOG\" target=\"_blank\">NOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441771-northern-oil-and-gasplus-10-after-strong-q4-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Oil and Gas +10% after strong Q4 earnings beat</a></h4><ul><li>Northern Oil and Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil and Gas, Inc.'>NOG</a>) <font color=\"green\">+10.3%</font> pre-market after routing <a href=\"https://seekingalpha.com/news/3441745-northern-oil-and-gas-beats-0_11-misses-oil-gas-sales\" target=\"_blank\">Q4 earnings</a> expectations and oil and gas sales more than doubled from the prior-year period.</li><li>NOG says Q4 production increased 117% Y/Y and 36% Q/Q to 3.34M boe, with the average realized oil price per barrel down 5% Y/Y and down 25% Q/Q; total production for the full year rose 73% to 9.33M boe, which       combined with a 28% rise in average realized oil price drove a 121%       increase in oil and gas sales to $494M.</li><li>Q4 production expenses fell 26% Y/Y to $6.43/bbl, and the company forecasts production expenses of $6.75-$7.75/bbl in FY 2019.</li><li>NOG expects 2019 capex of $247M-$285M, resulting in forecast full year production of 34.5K-35.5K boe/day with high       single-digit production declines in Q1       and growth resuming in Q2, Q3 and Q4.</li></ul><div class=\"tiny-share-widget\" data-id=\"3441771\" data-linked=\"Northern Oil and Gas +10% after strong Q4 earnings beat\" data-tweet=\"$NOG - Northern Oil and Gas +10% after strong Q4 earnings beat https://seekingalpha.com/news/3441771-northern-oil-and-gasplus-10-after-strong-q4-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3441771-northern-oil-and-gasplus-10-after-strong-q4-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3441767\" data-ts=\"1552389573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALQA\" target=\"_blank\">ALQA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3441767-alliqua-biomedical-news-correction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliqua BioMedical news correction</a></h4><ul><li>Alliqua BioMedical</li></ul><div class=\"tiny-share-widget\" data-id=\"3441767\" data-linked=\"Alliqua BioMedical news correction\" data-tweet=\"$ALQA - Alliqua BioMedical news correction https://seekingalpha.com/news/3441767-alliqua-biomedical-news-correction?source=tweet\" data-url=\"https://seekingalpha.com/news/3441767-alliqua-biomedical-news-correction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}